Final Programme - Société Marocaine de Rhumatologie

Transcription

Arab League Against Rheumatism
Lorem Ipsum Dolor / Lorem Ipsum Dolor
26th Congress of the Morrocan Society of Rheumatology
26e Congrès de la Société Marocaine de Rhumatologie
24-26 March 2016
Marrakech, Morocco
Final Programme
English / Français
ARLAR
Table of Content / Sommaire
Under the high patronage of his majesty the king mohammed vi
SOUS LE HAUT PATRONAGE DE SA MAJESTÉ LE ROI MOHAMMED VI
Sa Majesté le Roi Mohammed VI que Dieu l’Assiste
2
ARLAR Congress – Marrakech / 24-26 March 2016
www.arlar.org
3
ARLAR
Table of Content / Sommaire
General Information
Informations Générales
English
Contacts
5
Welcome Message
6–7
My Conference App
8
About ARLAR & Organizing Committees 9–12
Marrakech 13
Information from A to Z
14–16
Français
Mot de Bienvenue
L’ Application Mobile
ARLAR & les Comités d’Organisation
Informations de A à Z
Marrakech
Congress Centre Floorplan /
Plan du Palais des Congrès
18–19
20
21–24
25–27
28
29–31
33
Thursday, 24 March, 2016
Friday, 25 March, 2016
Saturday, 26 March, 2016
34–35
36–37
38–39
4
Contacts
Scientific Programme /
Programme Scientifique
Detailed Programme
Thursday, 24 March, 2016 Friday, 25 March, 2016 Saturday, 26 March, 2016 40–47
48–59
60–66
Posters /
Communications affichées 68–108
SMR
Société Marocaine de Rhumatologie
Immeuble 42, appartement 1
Avenue Al Abtal Agdal - Rabat
Tél./Fax : 05 37 68 19 59
Email : [email protected]
Site :
http://www.smr.ma
ARLAR 2016 Congress Secretariat
c/o K.I.T. Group GmbH
Email:[email protected]
www.arlar.org
Information about Sponsors and Exhibitors
Informations sur les sponsors et exposants
The Exhibition / L’exposition
116
Sponsor Information /
Nos Partenaires
117–122
Networking Dinner Accommodation and Travel /
Hotellerie et Billeterie
Scientific Programme /
Programme at a Glance /
Synopsis du Programme
123
Palais des Congrès de Marrakech
Avenue Mohamed VI , Marrakech 40 000 , Morocco
Tél :
+ 212 24 33 91 00
Fax :
+ 212 24 33 91 20 / 21
124
www.arlar.org
5
ARLAR
Welcome Message
Welcome Message
Dear Colleagues,
Dear Partners,
Dear Partners,
As Past President it is my privilege to be able to take this opportunity to thank
you once again for your contribution to making the 2014 PARC Congress in
Dubai the success it was. Together we have helped in the creation of ARLAR
and we have revived the Pan Arab Rheumatology.
The Moroccan Society for Rheumatology is proud to welcome the first Pan
Arab Rheumatology Congress in its new form ARLAR 2016, jointly organized
with its 26th National Annual Congress. We are honored to have the privilege
of organizing this event under the high patronage of his majesty the King
Mohammed VI.
Now as we work further towards fulfilling the stated mission of ARLAR I
would like to reach out to you once again, friends and colleagues, to ask for
your continued support in the Congress of Marrakech as it is the continuation
of what we successfully achieved together. ARLAR 2016 promises to be a
fine blend of science between the east and west of Arabic countries.
On my behalf and on behalf of Moroccan organizers, I am delighted to welcome
our rheumatology colleagues from the Arab world in Marrakech in 2016.
The choice of Marrakech was unanimous due to its excellent position in
the world which can welcome huge events and that are also attractive to
tourists. Marrakech gathers an important medical, scientific and university
community of not only the Arab world but also of the Asian, European and
American worlds.
During three days, about 800 colleagues, speakers and professionals of the
pharmaceutical industry will participate in the in-service training and the
consolidation of the partnership between rheumatology professionals and
the research world encased within the Arab world. This is an opportunity to
share and discuss the latest news of rheumatology. Our specialty knows,
indeed in recent years a wonderful progress. Better knowledge of the
causes and mechanisms of many rheumatic diseases allowed offering
innovative and effective treatments and now we can see clearly the benefits
for our patients.
Once again, this Congress does not only encourage the Young Arab
Rheumatologists, but is also a platform for all Rheumatologists in the
region to join and share their constructive views and significant expertise.
I look forward to being able to personally greet you once again.
Thanking you in advance,
Dr. Jamal Al Saleh
President of the Emirates Society for Rheumatology and past President of
ARLAR
Besides its scientific excellence through the conferences held by eminent
Arabic and foreign speakers, this meeting is the occasion to highlight the
research works led by Arabic departments of rheumatology.
I wish you all an excellent meeting and agreeable stay!
Prof. Abdellah El Maghraoui
President of the Moroccan Society for Rheumatology and current President
of ARLAR
6
www.arlar.org
7
ARLAR
My Conference App
About ARLAR & Organizing Committees
The ARLAR 2016 Conference App is available as a free download!
iPhone users can download the app directly from the iTunes Store. Android smartphone users
can download it from the Google Play Store.
Use the phrases « ARLAR » or « ARLAR2016 ».
Thanks to the mobile app of the congress you can plan your schedule and learn more about the
scientific program and the speakers as well as the sponsors and other partners.
Follow us on Twitter #ARLAR2016.
Ready to Start?
Click on the navigator icon on the top left of the screen to navigate through the menu bar.
Mission
In a world where alliances of different countries have made significant progress in the practice
of rheumatology by uniting under one umbrella, the time has come to form such a league in the
Arab world. It is our desire to facilitate the growth of the Pan Arab Rheumatology league through
improving research collaboration, patient education, and continuous professional development
of rheumatologists in the Arab countries.
We also take on initiatives from societies, individuals, and others stakeholders. The mission of
ARLAR is to represent Arab Rheumatologists as one of the top regional rheumatology leagues
in patient care, research, and education and promote joint and bone health and care through:
• Knowledge transmission, including dissemination of research and encouragement of best
practices
• Professional development and leadership in health policy
ARLAR, re-established in 2014 from the biennial meeting of Pan Arab Rheumatology, in its
current iteration, has organizational roots reaching back to 1995. The goals of the ARLAR
include advancing professional camaraderie, research and training to improve the health of
Arabs with rheumatic diseases. The ARLAR is composed of over 500 members throughout all 22
Arab League countries. As of today, ARLAR comprises seventeen Rheumatology Associations.
Vision
To be an internationally recognized, regional professional league.
Objectives
• To nourish previous achievements of Pan Arab Rheumatology League
• To facilitate the growth of the Pan Arab Rheumatology League
• To reset the Pan Arab Rheumatology long term goals for the next decade to position the
league as an internationally recognized scientific and professional power.
ARLAR Founding Countries
Morocco
Algeria
Bahrain
Egypt
Iraq
Jordan
Kuwait
8
www.arlar.org
Lebanon
Libya
Oman
Palestine
Qatar
Saudi Arabia
Sudan
Syria
Tunisia
United Arab Emirates
9
ARLAR
First Pan Arab Executive Committee
Samit Albadawy, Egypt
Fouad Nasr, Lebanon
Sultan Dhabera, KSA
Adnana Al-Eidan, Kuwait
Abdullah Dhalaan, KSA
Adel Al-Awaidi, Kuwait
Mohammed Reslan, Bahrain
Salwa Al Sheikh, Syria
Zuhair Sabbagh, Jordan
Ahmad Khalid, Egypt
Ahmad Alghabari, Egypt
Reda Awad, Egypt
Ayman Algarf, Egypt
Adel Al-Awaidi, Kuwait
Kuwait
Lebanon
Libya
Mauritania
Oman
Palestine
Qatar
Saudi Arabia
Somalia
Sudan
Syria
Tunisia
Yemen
Rheumatology Societies
Algeria
Morocco
Algerian Society for Rheumatology (SAR)
Moroccan Society for Rheumatology (SMR)
Algerian League Against Rheumatism (LAAR)
Jordan
Jordan Rheumatism Society (JRS)
Syria
Syrian Association For Rheumatology (SAR)
Lebanon
Lebanese Society of Rheumatology
Tunisia
Ligue Tunisienne Anti Rhumatismale (LITAR)
Libya
Libyan Rheumatology Society
Emirates Society for Rheumatology (ESR)
Arab Society Journals
The Emirates Medical Association
La Revue Marocaine de Rhumatologie
Emirates Cardiac Society
Emirates Intensive Care Medicine Society
The Arab Society for Medical Research
Gastroenterological Research and Practice in the Arab Region
Pan Arab Journal of Neurosurgery
Arab Journal of Urology
Arab Journal of Nephrology and Transplantation
Pan Arab Rhinology Society
The Arab Medical Association Against Cancer issue
Journal of the Pan Arab Orthopedic Association
Libye
10
Egypt
Saudi Arabia
Egyptian League Against Rheumatism (ELAR) Saudi Society of Rheumatology
Member Countries
Morocco
Algeria
Bahrain
Comoros Islands
Djibouti
Egypt
Iraq
Jordan
www.arlar.org
11
ARLAR
Surnamed the red city and located inside
lands, to the north of the foothills of the
Atlas Mountains, Marrakech is the fourth
largest city in Morocco. Marrakech counts
approximately 930,000 inhabitants spread on
a 230 km2 surface. The city is divided into two
parts: the Medina or the historic city and the
new city which has several districts.
Jamal Al Saleh
Rachid Bahiri
Ibtissam El Hamdaoui
Ihsane Hmamouchi
Houda Kadiri
Saloua Larhrissi
Noufissa Lazrak
Salaheddine Maaroufi
Radouane Niamane
Boubker Sedrati
Scientific Committee
Prof. Abdellah El Maghraoui – President, Morocco
12
Marrakech
Welcome to Marrakech
Organizing Committee
Prof. Abdellah El Maghraoui – President
Jamal Al Saleh, AUE
Fatima Abourazzak, Morocco
Ala’ Mohammad Al-Heresh,
Jordania
Sulaiman M Al-Mayouf,
Saudi Arabia
Humaid AlWahshi, Oman
Rachid Bahiri, Morocco
Ahmed Bezza, Morocco
Imane El Bouchti, Morocco
Ayman El Garf, Egypt
Take the opportunity to discover the city and
its surroundings by booking a tour or an
excursion at the First Class Travel desk in the
registration area.
Elnour Elagib, Soudan
Majda Khoury, Syria
Najia Hajja-Hassouni, Morocco Saloua Larhrissi, Morocco
Hussein Halabi, Saudi Arabia Noufissa Lazrak, Morocco
Btissam Hamdaoui, Morocco Salaheddine Maaroufi, Morocco
Mohammed Hammoudeh,
Ouafaa Mkinsi, Morocco
Qatar
Touzi Mongi, Tunisia
Taoufik Harzy, Morocco
Radouane Niamane, Morocco
Ihsane Hmamouchi, Morocco Samira Rostom, Morocco
Linda Ichchou, Morocco
Latifa Tahiri, Morocco
Houda Kadiri, Morocco
www.arlar.org
13
ARLAR
Abstract CD
The Abstracts are accessible on the website
of the conference www.arlar.org.
Cash Machine
Three banks are located very close to
the Palais des Congrès on the Boulevard
Mohamed VI.
Catering (Coffee Breaks and Lunch Breaks)
A coffee-break will be available to all delegates
in the exhibition area from Thursday, 24 to
Saturday, 26 March as follows:
Morning Coffee-Break
10:20 – 10:45
Afternoon Coffee-Break
16:05 – 16:30
A lunch buffet is included in the registration
and will be distributed in the exhibition area on
Thu., 24 and Sat., 26 March 13:15 – 14:15
Fri., 25 March 12:30 – 13:30
and 13:30 – 14:15
Certificate of Attendance
Please pick up your Certificate of Attendance
from our self-printing terminal in the registration
area from Friday, 25 March at 13:00. You will
need to use the barcode on your badge for this.
Cloakroom and Luggage Service
A cloakroom is available in Espace Agdal on level 0.
Conference Bag
The conference bag containing the conference
materials can be collected from the bag
counter on level 0. Please ensure you have
the voucher from your badge ready when
collecting your conference bag.
14
Currency
The official currency in Morocco is the
Moroccan Dirham (MAD). Payments on site
can only be made either by credit card or
cash in USD.
for personal injury, loss of or damage to
belongings of conference participants, either
during or as a result of the conference.
Please check the validity of your own
insurance.
Entitlements
The registration fees include:
• Admission to all scientific sessions
• Admission to the exhibition area
• Coffee breaks, lunches and welcome
reception
• Congress Bag containing Program
Internet Access
Wireless LAN will be available to all participants
free of charge in the conference venue.
Network: ARLAR2016 / Password: Marrakech
Exhibition
Conference participants are invited to visit
the exhibition area during the conference.
The exhibition area will be open during the
following times:
Thursday, 24 March
09:00 – 19:45
Friday, 25 March
09:00 – 18:30
Saturday, 26 March
09:00 – 18:30
Filming and Taking Pictures
Out of respect for authors’ and speakers’
copyrights, it is forbidden to take pictures
and/or to film during any official conference
sessions. In case of negligence, the
organizers reserve the right to exclude the
participant from the conference.
Official photographers and videographers
are authorized to take photographs and film
sessions as well as participants during the
conference.
Internet Lounge
A working area is available in Salle Royale
inside the exhibition to allow the attendees to
work and surf on internet.
Language
The official language of the conference
are English and French. Please note that
simultaneous interpretation (English and
French only) is available for all presentations
held in Salle des Ministres (Thursday) and
in Salle des Ambassadeurs (Friday and
Saturday).
Simultaneous
interpretation
headsets will be provided. Workshops and
parallel sessions will be held either in English
or in French.
Lost and Found
Lost objects should be returned to the
registration desk.
Mobile Phones
Mobile phones must be set to silent mode in
all session rooms at all times.
Insurance and Liability
The conference organizer and the ARLAR
Conference Secretariat do not accept liability
www.arlar.org
Moroccan Handcraft Village
Discover some various aspects of the traditional
Moroccan Handcraft in the Menara Area.
Name Badge
The name badge must be worn at all times
during the conference. Access to the
conference facilities will not be granted
without a proper name badge. If an attendee
loses, misplaces or forgets the name badge,
a handling fee of 40 USD will be charged for
a new name badge. Upon handing out a new
name badge, the lost badge will become
invalid.
Networking Dinner
Come and meet us for a dinner away from the
bustle of the Congress, in the center of the
palm grove in order to share the rhythms and
values dear to the Marrakchi hospitality.
Beautiful and authentic, Chez Ali represents
the best the art of Moroccan conviviality
around a dinner full of local flavours. We will
share an unforgettable moment punctuated
with performances and traditional dances.
Price : 65 USD (including transport). Tickets
for sale in the registration area until Friday, 25
March.
Departure at 20:00 in front of Palais des
Congrès. More information at First Class
travel desk in the registration area.
Opening Ceremony
You are cordially invited to attend the Opening
Ceremony at 17:45 on Thursday, 24 in
Salle des Ministres, followed by a Welcome
Reception and an entertainment.
15
ARLAR
Posters
Posters than have been printed onsite can
be picked-up in the registration area during
the opening times of the registration desks
(see below ‘Registration’). Poster authors are
kindly asked to stay in front of their poster
during the coffee-breaks to answer to the
questions of delegates
Prayer Room
A prayer room is available at any time in room
Karam 5 on level -1.
A bus transfer to the Mosque will take place
on Friday, 25 March at 12:20 for the Friday
Prayer
Program Changes
The organizers cannot assume liability for
any changes in the program due to external
or unforeseen circumstances. The organizers
reserve the right to cancel, postpone, relocate
or change any of the sessions.
Registration
Please bring your confirmation to the
conference venue and go directly to the selfprinting terminals in the registration area.
The barcode on the document will allow you
to print your conference name badge. You can
then pick up your conference material at the
bag counter.
The registration desks are open during the
following times:
Wednesday, 23 March
17:00 – 21:00
Thursday, 24 March
07:00 – 18:00
Friday, 25 March
07:00 – 18:00
Saturday, 26 March
08:00 – 18:00
16
Notes / Notes
Smoking Policy
It is forbidden to smoke in any part of the
conference venue.
Speakers’ Center
Invited speakers, chairs and oral abstract
presenters must report to the Speakers’
Center at least two hours prior to their
presentation, in order to check and deposit
their presentation.
The Speakers’ Center is located in room Reda 3
on level -1.
Opening hours:
Thursday, 24 March
Friday, 25 March
Saturday, 26 March
07:30 – 18:00
07:30 – 17:30
07:30 – 17:30
Taxi
Taxis verts: +212 (0)5 24 40 94 99
Tours and Excursions
You have the possibility to book a tour on site
at the First Class Travel desk located in the
registration area.
Twitter
Send your tweets about the conference
on #ARLAR2016.
Webcasts
All sessions except the Task Force workshops
will be recorded and webcasted on the ARLAR
website after the conference.
www.arlar.org
17
ARLAR
Mot de Bienvenue
Mot de Bienvenue
Chers collègues,
Chers partenaires,
Chers partenaires,
En tant qu’ancien président, je tiens à vous remercier de nouveau pour votre
contribution au succès du Congrès PARC qui s’est tenu à Dubaï en 2014.
Ensemble, nous avons créé ARLAR et fait revivre la rhumatologie panarabe.
La Société Marocaine de Rhumatologie est fière d‘accueillir le 1er Congrès
Panarabe de Rhumatologie dans sa nouvelle forme sous la bannière ARLAR
2016, organisé conjointement avec son 26e Congrès National Annuel, et
pour lequel elle a le privilège de recevoir le Haut Patronage de Sa Majesté
le Roi Mohammed VI.
Alors que nous travaillons pour l’accomplissement de la mission d’ARLAR,
je m’adresse à vous, amis et collègues, pour vous demander de renouveler
votre soutien pour le Congrès de Marrakech. Il s’agit de la continuation de
ce que nous avons déjà accompli ensemble. ARLAR 2016 promet d’être un
fin mélange de science entre les pays arabes de l’est et ceux de l’ouest.
En mon nom et en celui des organisateurs marocains, je suis ravi de
souhaiter la bienvenue à nos collègues rhumatologues du monde arabe à
Marrakech en 2016.
Marrakech, dont le choix a fait l’unanimité de par sa place au diapason
mondial des villes d’accueil des grandes manifestations et d’attractivité
touristique, réunit aujourd’hui une communauté médicale, scientifique et
universitaire importante du Monde Arabe, mais aussi d’Asie, d’Europe, et
d’Amérique du Nord.
Durant 3 jours, près de 800 collègues, orateurs et professionnels de
l’industrie pharmaceutique, participent à la promotion de la formation
continue et à la consolidation du partenariat entre les professionnels de
la rhumatologie et la recherche au sein du monde arabe. C’est l’occasion
de partager et discuter les dernières actualités de la rhumatologie. Notre
spécialité connaît, en effet depuis quelques années un essor formidable.
La meilleure connaissance des causes et des mécanismes de nombreuses
maladies rhumatismales devant lesquelles la médecine était impuissante
a permis de proposer des traitements innovants et efficaces dont nous
apprécions aujourd‘hui le bénéfice sur nos malades.
Une fois de plus, ce Congrès n’encourage pas seulement les jeunes
rhumatologues arabes mais se veut aussi être une plateforme de partage
pour tous les rhumatologues de la région, afin de partager opinions et
expertise.
Dans l’attente de vous accueillir à Marrakech, je vous remercie par avance.
Dr. Jamal Al Saleh
Président de la Société des Rhumatologues des Emirats et ancien président
de ARLAR
En plus de son niveau scientifique élevé à travers des conférences
d‘enseignement prodiguées par d‘éminents orateurs arabes et étrangers,
ce congrès offre également un très bon espace de mise en valeur des divers
travaux de recherche menés par des services de rhumatologie arabes, au
travers de séances de communication orales ou affichées.
Je vous souhaite à tous un excellent congrès et un agréable séjour!
Prof. Abdellah El Maghraoui
Président de la Société Marocaine de Rhumatologie et actuel Président
de ARLAR
18
www.arlar.org
19
ARLAR
L’ Application Mobile
L’application de la Conférence ARLAR 2016 est disponible en
téléchargement gratuit !
Les utilisateurs d’iPhone peuvent télécharger l’application directement depuis iTunes Store ; à
partir des smartphones Android, elle est téléchargeable depuis le Google Play Store.
Pour se connecter saisir “ARLAR” ou “ARLAR2016”.
Grâce à l’appli mobile du congrès vous pouvez planifier votre agenda et en savoir plus sur le
programme scientifique, les conférenciers ainsi que les sponsors et autres partenaires.
Rejoignez-nous également sur Twitter #ARLAR2016
Vous êtes prêts?
Cliquez sur l’icône du navigateur en haut à gauche de votre écran afin de naviguer dans la barre
de menu.
Soyez le plus nombreux possible à télécharger l‘appli !
Mission
ARLAR a pour mission de représenter les rhumatologues arabes et de promouvoir la poursuite
de l’excellence dans le traitement des maladies rhumatismales, la formation et la recherche.
Réseautage professionnel, recherche et formation constituent ses axes de travail principaux afin
d’améliorer dans le monde arabe, la santé de patients souffrant de maladies rhumatismales.
Créée en 2014 à Dubai, et constituée de 17 sociétés savantes à travers 22 pays, la Ligue a pour
ambition de se positionner comme organisation scientifique régionale reconnue à l’international.
A ce jour, ARLAR englobe 17 associations de rhumatologie.
Objectifs :
• Parfaire les enseignements antérieurs de la Ligue Panarabe de Rhumatologie
• Promouvoir son développement
• Fixer ses nouveaux objectifs à long terme pour la décennie à venir afin de la positionner en
tant qu’organisation scientifique et professionnelle reconnue à l’international.
Pays Fondateurs
Maroc
Algérie
Saudi Arabia
Bahreïn
Egypte
Emirats Arabes Unis
Iraq
Jordanie
Koweït
Liban
Libye
Oman
Premier Comité Exécutif Panarabe
Samit Albadawy, Egypte
Fouad Nasr, Liban
Sultan Dhabera, Saudi Arabia Adnana Al-Eidan, Koweit
Abdullah Dhalaan,
Adel Al-Awaidi, Koweit
Saudi Arabia
Salwa Al Sheikh, Syrie
Mohammed Reslan, Bahrain
Ahmad Khalid, Egypte
Zuhair Sabbagh, Jordanie
20
www.arlar.org
Palestine
Qatar
Soudan
Syrie
Tunisie
Ahmad Alghabari, Egypte
Reda Awad, Egypte
Ayman Algarf, Egypte
Adel Al-Awaidi, Koweit
21
ARLAR
Pays Membres
Maroc
Algérie
Saudi Arabia
BahreÏn
Djibouti
Egypte
Emirats Arabes Unis
Iles Comores
Iraq
Jordanie
KoweÏt
Liban
Libye
Mauritanie
Oman
Palestine
Qatar
Somalie
Soudan
Syrie
Tunisie
Yémen
Sociétés de Rhumatologie
Algérie
Société Algérienne de Rhumatologie (SAR)
Ligue Algérienne AntiRhumatismale (LAAR)
Maroc
Société Marocaine de Rhumatologie (SMR)
Egypte
Arabie Saoudite
Ligue Égyptienne contre le Rhumatisme (ELAR) Société Saoudienne de Rhumatologie
Jordanie
Société Jordanienne de Rhumatisme (JRS)
Syrie
Association Syrienne de Rhumatologie (SAR)
Liban
Société Libanaise de Rhumatologie
Tunisie
Ligue Tunisienne Anti Rhumatismale (LITAR)
Libye
Société Libyenne de Rhumatologie
Émirats Arabes Unis
Société Émiratie de Rhumatologie (ESR)
Journaux des Sociétés Arabes
The Emirates Medical Association
La Revue Marocaine de Rhumatologie
Emirates Cardiac Society
Emirates Intensive Care Medicine Society
The Arab Society for Medical Research
Gastroenterological Research and Practice in the Arab Region
Pan Arab Journal of Neurosurgery
Arab Journal of Urology
Arab Journal of Nephrology and Transplantation
Pan Arab Rhinology Society
The Arab Medical Association Against Cancer issue
Journal of the Pan Arab Orthopedic Association
Libye
22
www.arlar.org
23
ARLAR
Comité d’Organisation
Abdellah El Maghraoui – Président
Assurance et Responsabilité
L'organisateur de la conférence ainsi que
le secrétariat de la conférence ARLAR ne
sont pas tenus pour responsables en cas de
préjudice, de perte ou d'endommagement
des effets personnels du participant, et ce
aussi bien pendant qu'après le congrès.
Merci de vérifier la validité de vos propres
assurances.
Jamal Al Saleh
Rachid Bahiri
Ibtissam El Hamdaoui
Ihsane Hmamouchi
Houda Kadiri
Saloua Larhrissi
Noufissa Lazrak
Salaheddine Maaroufi
Radouane Niamane
Boubker Sedrati
Badge
Le badge doit être porté pendant toute la
durée de la conférence. Un participant ne
portant pas son badge nominatif se verra
refuser l'accès à toute installation du congrès.
En cas de perte, le badge de remplacement
lui sera facturé 40 USD. Tout badge remplacé
ne sera plus valable.
Comité Scientifique
Prof. Abdellah El Maghraoui – Président, Maroc
Jamal Al Saleh, EAU
Fatima Abourazzak, Maroc
Ala’ Mohammad Al-Heresh,
Jordanie
Sulaiman M Al-Mayouf,
Saudi Arabia
Humaid AlWahshi, Oman
Rachid Bahiri, Maroc
Ahmed Bezza, Maroc
Imane El Bouchti, Maroc
Ayman El Garf, Egypte
Elnour Elagib, Soudan
Najia Hajja-Hassouni, Maroc
Hussein Halabi, Saudi Arabia
Btissam Hamdaoui, Maroc
Mohammed Hammoudeh,
Qatar
Taoufik Harzy, Maroc
Ihsane Hmamouchi, Maroc
Linda Ichchou, Maroc
Houda Kadiri, Maroc
Majda Khoury, Syrie
Saloua Larhrissi, Maroc
Noufissa Lazrak, Maroc
Salaheddine Maaroufi, Maroc
Ouafaa Mkinsi, Maroc
Touzi Mongi, Tunisie
Radouane Niamane, Maroc
Samira Rostom, Maroc
Latifa Tahiri, Maroc
Centre des orateurs
Les orateurs, présidents et auteurs de
résumés qui présentent leur travail à l'oral
doivent télécharger leur présentation au
centre des orateurs au moins 2 heures avant
leur présentation. Le centre des orateurs est
situé en salle Reda 3 au niveau -1.
Heures d'ouverture :
Jeudi 24 mars
Vendredi 25 mars
Samedi 26 mars
07:30 – 18:00
07:30 – 17:30
07:30 – 17:30
Certificat de présence
Pensez à retirer votre certificat de présence
à notre terminal d'auto-impression dans la
zone d'enregistrement à partir de Vendredi
25 mars à 13:00. Vous aurez pour cela besoin
d'utiliser le code-barres de votre badge.
24
www.arlar.org
Changements de programme
Les organisateurs ne pourront pas être tenus
pour responsables en cas de changements
de programme liés à des facteurs externes
ou à des circonstances imprévues. Les
organisateurs se réservent le droit d'annuler,
de repousser, de délocaliser ou de changer
toute session.
Distributeur automatique de billets
Trois banques sont situées à proximité
immédiate du Palais des Congrès sur le
Boulevard Mohamed VI.
Droits d‘inscription
Les droits d‘inscription incluent:
• Accès à toutes les sessions scientifiques
• Accès à la zone d‘exposition
• Pauses café, déjeuners et réception de
bienvenue
• Sacs de congrès contenant le programme
Exposition
Les participants au congrès sont invités à
visiter la zone d‘exposition durant le congrès.
La zone d‘exposition sera accessible aux
heures suivantes:
Jeudi 24 mars
09:00 – 19:45
Vendredi 25 mars
09:00 – 18:30
Samedi 26 mars
09:00 – 18:30
Fumeurs
Il est interdit de fumer dans l‘enceinte de
l‘établissement du congrès.
Inscription
Merci
d‘apporter
votre
confirmation
d‘inscription en arrivant au congrès et de
25
ARLAR
vous rendre directement aux terminaux
d‘auto-impression. Le code-barres sur le
document vous permettra d‘imprimer votre
badge personnel pour le congrès. Vous
pourrez ensuite récupérer votre matériel
pour le congrès au comptoir des sacoches.
Les bureaux d‘enregistrement sont ouverts
aux heures suivantes :
Mercredi 23 mars
17:00 – 21:00
Jeudi 24 mars
07:00 – 18:00
Vendredi 25 mars
07:00 – 18:00
Samedi 26 mars
08:00 – 18:00
Internet
Le réseau local sans fil et gratuit sera
accessible à tous les participants.
Réseau : ARLAR2016
mot de passe: Marrakech
Langue
Les langues officielles du congrès sont l'anglais
et le français. Des interprétations simultanées
(en anglais et français) auront lieu pour toutes
les présentations en Salle des Ministres
(jeudi) et Salle des Ambassadeurs (vendredi et
samedi). Les ateliers et sessions en parallèle
se feront soit en anglais soit en français.
Lounge Internet
Une zone de travail est disponible en Salle
Royale au sein de l‘exposition pour vous
permettre de travailler et surfer sur internet.
Monnaie
La monnaie officielle au Maroc est le Dirham
marocain (MAD). Les paiements sur place
peuvent être effectués soit par carte bancaire,
soit en espèces en USD.
26
Objets trouvés
En cas d‘objets trouvés ou perdus, prère de
vous adresser au comptoir des inscriptions.
Résumés
Les résumés sont disponibles sur le site de la
conférence www.arlar.org
Photo et vidéos
Par respect des droits d'auteur des orateurs
présents, il est interdit de prendre des photos
ou des vidéos lors des sessions de conférences
officielles. En cas de non-respect de cette
règle, les organisateurs se réservent le droit
d'exclure le participant du congrès.
Les photographes et cameramen officiels, tout
comme les participants, sont autorisés à prendre
des photos ou à filmer durant le congrès.
Sacoche du congrès
La sacoche du congrés contenant entre
autres le programme final est à récupérer au
comptoir du niveau 0. Merci de vous munir de
votre bon sur votre badge lorsque vous venez
récupérer votre sac.
Posters
Les auteurs ayant fait imprimer leur poster
sur place peuvent venir le chercher dans
l’espace inscriptions aux heures d’ouverture
des comptoirs d’inscription. Tous les auteurs
de posters sont priés de rester devant leur
poster pendant les pauses-café afin de
répondre aux questions des participants.
Restauration
(Pauses café et pauses déjeuner)
Une pause-café sera disponible pour tous les
délégués dans la zone d'exposition du Jeudi
24 au Samedi 26 mars :
le matin
10:20 – 10:45
l‘après-midi
16:05 – 16:30
Un déjeuner buffet est inclus dans la
réservation et sera disponible dans la zone
d'exposition le
Jeudi 24 et Samedi 26 mars 13:15 – 14:15
Vendredi 25 mars
12:30 – 13:30
et 13:30 – 14:15
Salle de prière
Une salle de prière est à votre disposition à
tout moment en salle Karam 5.
Un transfert en bus à la Mosquée aura lieu
le vendredi 25 mars à 12:20 pour la Prière du
Vendredi
Séance inaugurale
Vous êtes cordialement invité à l‘inauguration
officielle du Congrès en Salle des Ministres
le jeudi 24 à 17:45, suivie d‘une animation
artistique et d‘un cocktail dînatoire.
Soirée Networking
Afin de marquer une pause et se retrouver
pour un moment de partage loin de
l’effervescence du congrès, une soirée est
proposée aux participants dans l’un des
plus emblématiques lieux authentiques au
cœur de la Palmeraie. Divertissement et
découverte seront au rendez-vous autour
d’un dîner aux rythmes des saveurs et de l’art
marrakchis .
Participation aux frais 65 USD - Transport
assuré au départ du Palais des Congrès à
20:00 Adressez vous au desk First Class
Travel pour tout renseignement.
www.arlar.org
Taxi
Taxis verts : +212 (0)5 24 40 94 99
Téléphones portables
Les téléphones portables doivent être mis en
mode silencieux avant d‘entrer dans une salle
de session.
Tours et Excursions
Vous avez la possibilité de réserver un tour
sur place au comptoir de l‘agence First Class
Travel en zone d'inscription.
Twitter
Envoyez-nous vos tweets à propos du congrès
à #ARLAR2016.
Vestiaire et bagagerie
Un vestiaire est disponible à l‘espace Agdal
au niveau 0.
Village artisanal
Une invitation à découvrir quelques facettes
de l’art traditionnel marocain dans l’espace
Menara
Web Diffusion
Toutes les sessions (sauf les ateliers
taskforce) seront enregistrées et diffusées
sur le site web de ARLAR après la conférence.
27
ARLAR
Marrakech
Congress Centre Floorplan / Plan du Palais des Congrès
Bienvenue à Marrakech
Level -1 / Niveau -1
Surnommée la ville rouge et située dans
les terres au pied des montagnes de l’Atlas,
Marrakech est la quatrième plus grande ville
du Maroc. Marrakech compte 230 kilomètres
carrés pour environ 930 000 habitants. La
ville est divisée en deux parties : La Medina
ou ville historique et la ville nouvelle.
Vous avez la possibilité de réserver des
visites de la ville ou une excursion dans
les environs de Marrakech au comptoir de
l‘agence First Class Travel situé dans la zone
des inscriptions.
Reda 4
Reda 3
Speakers
Preview
Room
Karam 2
Reda 5 Karam 5
Secrétariat Salle de
SMR
Prière
Reda 2
Karam 1
Salle des
Ministres
Salle des
Ambassadeurs
Plenary rooms / Salles plénières
Session and workshop rooms / Salles de session et d'atelier
Meeting rooms / Salles de réunion
28
www.arlar.org
29
ARLAR
Level 0 / Niveau 0
Level 1 / Niveau 1
Lunch Break /
Pause Déjeuner
Exhibition /
Exposition
Posters
Salle Royale
Fès 1
Salle des Ministres
Salle des Ministres
Registration / Inscriptions
Cloakroom / Vestiaire
30
Fès 2
www.arlar.org
31
ARLAR
Scientific Programme / Programme Scientifique
Programme at a Glance / Synopsis du Programme
Legend
Plenary Lecture / Lecture Plénière
Abstract Sessions / Communications Orales
Meet The Experts / Rencontre avec les Experts
Inauguration / Ouverture
Parallel Session / Session Parallèle
Symposium / Symposium
Ultrasound Workshop / Atelier Ultrasound
Selected Abstracts for Plenary Session / Résumés choisis pour les Plénières
Pediatric Rheumatology / Rhumatologie Pédiatrique
Scientific Programme
Workshop / Atelier
Non-webcasted session
Translated session English/French French/English *
*Please note that simultaneous interpretation (English and French only) is available for
all presentations held in the Salle des Ministres and in the Salle des Ambassadeurs.
Simultaneous interpretation headsets will be provided.
Workshops and parallel sessions will be held either in English or in French.
*Des casques d’interprétation simultanée (anglais et français uniquement) seront
disponibles pour toutes les présentations se tenant dans la Salle des Ministres et dans la
Salle des Ambassadeurs.Les ateliers et sessions parallèles se dérouleront en anglais ou
en français.
32
www.arlar.org
33
ARLAR 24 March, 2016
Thursday,
Time
08:30
Salle des Ministres
Fès 2
08:30-09:20
08:30-09:20
Protéines alimentaires
Spondylarthropathies:
et os
an update
Khalid Abdallah Alnaqbi - UAE René Rizzoli - Suisse
Karam 1
08:45
09:00
09:15
09:30-10:20
Spondyloarthritis (SpA) diagnosis;
update on management
immunopathogenesis of AS
Bassel El Zorkany - Egypt
09:30
09:45
10:00
Arab League
Against 24
Rheumatism
Thursday,
March, 2016
Fès 1
Karam 2
Reda 2
Reda 4
09:00 – 10:30
Echographie débutants /
intermédiaires :
Echographie de l‘épaule
Ahmed Bezza - Maroc
Noufissa Lazrak - Maroc
09:00-10:30
Echo débutants /
intermédiaires :
Echographie du genou
Samy Slimani - Algérie
Salle Royale
Time
Lorem Ipsum Dolor / Lorem Ipsum Dolor 08:30
08:45
09:00-10:20
Abstract session RA
09:30-10:20
Consommer des produits
laitiers : un danger ?
Fadoua Allali - Maroc
09:00
09:15
09:30
09:45
10:00
10:15
10:20-10:45
10:15
10:30
Poster Viewing in the Exhibition Area / Coffee Break
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
10:45-12:15
PLENARY
LECTURE 1
10:45
11:00
· Management of co-morbidities
11:15
associated with rheumatoid
arthritis – practical aspects
· Spondyloarthritis update on
pathogenesis, diagnosis and
management
· State of the art in RA
management
11:30
11:45
12:00
12:20-13:20
SYMPOSIUM
PFIZER
12:15
12:30
12:45
12:45
13:00
13:00
13:15
13:15-14:15
Lunch Break*
13:45
13:15-14:15
Lunch Break*
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
14:15-15:45
PLENARY
LECTURE 2
· Osteoarthritis and
obesity: an association
more complex than
expected
· Ultrasound practice in
rheumatology
· Why gout must be treated
15:45-16:15
Selected Abstracts for
Plenary Lecture 2
16:15
16:30
16:45
13:15
09:00-19:45
13:30
14:15-15:05
Comorbidities
management in RA
Maxime Dougados - France
15:15-16:05
Dose tapering of biologic
agent in reumatoid arthritis
Boulos Haraoui - Canada
14:15-15:05
Les traitements des
spondyloarthrites après
échec des anti-TNF
Ouafa Mkinsi - Maroc
14:45-16:05
Abstract session AS
13:30
Exhibition
13:45
Posters
14:15
14:00
14:30
Coffee-Breaks
14:45
and Lunch Breaks
15:00
15:15-16:05
Treat to target dans
la spondylarthrite
ankylosante
Mongi Touzi - Tunisia
16:05-16:30
15:15
15:30
15:45
16:00
16:05-16:30
16:15
16:30-17:30
SYMPOSIUM
ABBVIE
16:30
16:45
17:00
17:00
17:15
17:15
17:30
17:45
18:00
17:30
17:45-19:45
INAUGURATION
17:45
18:00
18:15
18:15
18:30
18:30
18:45
18:45
19:00
19:00
19:15
19:30
34
Congress
– Marrakech
/ 24-26 March 2016
* ARLAR
Lunch kindly
sponsored
by
www.arlar.org
35
19:15
19:30
ARLAR
Friday,
25 March, 2016
Time
08:30
08:45
09:00
Emmanuel Maheu - France 09:00-10:20
09:15
09:30-10:20
PRP en rhumatologie:
Efficacité et controverse
Fadoua Allali - Maroc
09:30
09:45
10:00
11:00
11:15
11:30
11:45
12:00
Abstract session :
miscellaneous
Karam 2
Reda 2
08:30-10:20
Pediatric rheumatology Session I
09:00-10:30
US beginners / intermediate : Knee ultrasound
Reda 4
Salle Royale
Time
08:45
09:00-10:30
US beginners / intermediate : ankle ultrasound
Rachid Bahiri - Maroc
Ghita Harifi - UAE
09:00
09:15
09:30
09:45
10:00
10:15
10:20-10:45
10:30
10:45
Karam 1
10:15
Arab LeagueFriday,
Against Rheumatism
25 March, 2016
Salle des Ambassadeurs Fès 1
Fès 2
08:30-09:20
08:30-09:20
Inflammatory myopathies Les acides hyaluroniques
Khader Mustafa - Jordan en pratique
10:45-12:15
PLENARY
LECTURE 3
· Fat, muscle, osteoporosis
and inflammation
· Vitamin D: where do we
stand?
· Glucocorticoid induced
osteoporosis
10:30
10:45-12:15
Parallel Session 1
10:45-12:15
10:45-12:15
Pediatric rheumatology - US beginners/intermediSession II
ate: wrist ultrasound
Hanan Rkain
Souad Aktaou - Maroc
· Rheumatoid arthritis, past
and present: the Moroccan
experience
· RA registry in Qatar
11:30-12:15
· Where are we in biologic Symposium Roche
therapy and registry?
10:45-12:15
Echographie intermédiares / avancés: Echo
abarticulaire: tendons
méconnus
Fatima Ezzahra
Abourazzak
Latifa Tahiri - Maroc
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:15
12:30
12:30
12:45
12:38 PRAYER
12:38 PRAYER
13:00
13:15
13:15-14:15
Lunch Break*
13:30
13:45
13:15-14:15
Lunch Break*
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
14:15-15:45
PLENARY
LECTURE 4
14:15-16:15
Parallel Session 2
· Rituximab en 1ère intention Expérience marocaine
· Rehabilitation of rotator cuff
· Manifestations rhumatologiques
disease
du diabète
· Management of frozen
· Regards bibliométriques sur
shoulder in 2016
la production scientifique des
· Critical lecture of the
osteoarthritis guidelines (ACR, principaux pays arabes dans le
domaine de la rhumatologie
AAOS, OARSI, ESCEO)
· Apport du cinéma documentaire
en rhumatologie: expérience
15:45-16:15
d’un rhumatologue marocain
14:15-15:05
14:15-15:05
MRI Sacro-iliac joints
Quizz Imagerie
Philippe Gaudin - France and spine: pitfalls and
differential diagnosis
Ghita Harifi - UAE
15:05-16:20
Abstract session:
15:15-16:05
OA - bone
Aspets échographiques
de la goutte
Hanan Rkain - Maroc
Selected abstracts for
Plenary Lecture 4
16:05-16:30 Poster Viewing in the Exhibition Area / Coffee Break
16:30-17:30
SYMPOSIUM HIKMA
14:00-16:15
Pediatric rheumatology 14:15-15:15
Session III
General
Assembly
ARLAR
09:00-18:30
12:45
Exhibition
13:00
13:15
Posters
13:30
Coffee-Breaks
13:45
and Lunch Breaks
14:00
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:05-16:30 Poster Viewing in the Exhibition Area / Coffee Break
16:30
16:45
17:00
17:00
17:15
17:30
17:45
18:00
17:15
17:30-18:30
General
Assembly
SMR
17:30-18:20
Actualités du traitement
de l‘ostéoporose
Christian Roux - France
17:30-18:20
Challenging cases in RA
management
Hani Almoallim - KSA
17:30-18:20
Challenging cases
in Rheumatology
Samy Slimani - Algeria
17:30-18:30
Pediatric rheumatology Session IV
17:30
17:45
18:00
18:15
18:15
18:30
18:30
18:45
18:45
19:00
19:00
19:15
36
Congress
– Marrakech
/ 24-26 March 2016
* ARLAR
Lunch kindly
sponsored
by
www.arlar.org
37
19:15
ARLAR 26 March, 2016
Saturday,
Time
08:30
08:30-09:20
An interactive workshop on
imaging in SPA with tips on
how to read MRI in SPA an 2 or
3 interactive case studies
Bassel El Zorkany - Egypte
09:00
09:15
09:30-10:20
Disease activity
assessment – assets
and limitations
Josef Smolen - Austria
09:30
09:45
10:00
10:15
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
Karam 1
08:30-09:20
Gestion de la douleur
neuropathique en
pratique
Linda Ichchou - Maroc
Karam 2
08:30-09:30
Registry task
force in RA
(supported by
Pfizer)
Reda 2
08:30-09:20
management of
crystal arthritis
Reda 4
Salle Royale
Time
09:30-10:20
La DXA en pratique
Abdellah El Maghraoui
- Maroc
09:30-10:20
Evaluation de la qualité
de vie en rhumatologie
Samira Rostom - Maroc
9:30-10:30
Registry task
force in Lupus
09:30
08:45
09:00-10:30
Echographie intermédiaires / avancés : Echographie interventionnelle,
principes et pratiques
Philippe Gaudin - France
09:00
09:15
09:45
10:00
10:15
10:20-10:45
10:30
10:45
Fès 2
08:30-09:20
Prise en charge de
l‘arthrose digitale
Emmanuel Maheu France
08:45
Arab League
Against Rheumatism
Saturday,
26 March, 2016
Salle des Ambassadeurs Fès 1
10:45-12:15
PLENARY
LECTURE 5
· Clinical significance of
interleukin-23 and its receptor
gene polymorphism in Behçets
disease
· Large vessel vasculitis (LVV)
· Acute rheumatic fever and
poststreptococcal reactive
arthritis: from infection to
immune disorders
10:45-11:35
Evaluation du risque
fracturaire par TBS
Hans Didier - Suisse
10:30
10:45-11:35
Cas cliniques
en rhumatoogie
10:45-12:15
Ultrasound
training in
rheumatology:
sharing the experience
in the Arabic world
Waleed Alshehhi - UAE
11:35-12:25
La maladie de Behçet
en 2016
Zoubida Tazi - Maroc
10:45-12:15
Echographie intermédiaires / avancés : Echographie du coude
Hanan Rkain - Maroc
Souad Aktaou - Maroc
10:45-12:15
Echographie intermédiaires / avancés : Echographie de la cheville
Rachid Bahiri - Maroc /
Ghita Harifi - UAE
10:45
11:00
11:15
11:30
11:45
12:00
12:20-13:20
SYMPOSIUM
JANSSEN
12:15
12:30
12:45
13:00
09:00-18:30
13:15
Exhibition
13:15
Posters
13:30
13:30
13:15-14:15
Lunch Break**
13:45
13:15-14:15
Lunch Break**
14:00
14:15
14:30
14:45
15:00
15:15
15:30
14:15-16:15
PLENARY
LECTURE 6
· Antiphospholipid
syndrome
· Lupus in 2016
· SLE and pregnancy
· Juvenile idiopathic
arthritis: state of the art
15:45
16:00
14:15-16:15
Parallel Session 3
· Hépatites virales et
biothérapies
· Actualités du rhumatisme
psoriasique
· Marqueurs du remodelage
osseux: quel intérêt
dans la stratégie antiostéoporose?
· La monothérapie dans
la PR
16:15
16:30-17:20
Optimizing withrawal
of therapy to sustain
remission in RA
Mohammed Hammoudeh
- Qatar
16:30
16:45
17:00
17:15
13:00
13:45
Coffee-Breaks
14:00
and Lunch Breaks
14:15-15:05
Examen du pied
Hanan Rkain - Maroc
14:15
14:30
14:45
15:00
15:15-16:05
Rôle de la rééducation
dans la prise en charges
des lombalgies chroniques
Meriem Fourtassi - Maroc
16:05-16:30
Poster Viewing in the Exhibition Area /
Coffee Break
16:30-17:20
Web based software to
monitor RA , psoriatic
arthritis and ankylosing
spondylitis patients
Rafic Baddoura - Lebanon
15:15
15:30
15:45
16:05-16:30
Poster Viewing in the Exhibition Area /
Coffee Break
16:00
16:15
16:30-17:30
Workshop pregnancy
in rheumatic diseases
16:30
16:45
17:00
17:15
17:30
17:30
17:45
17:45
18:00
18:00
18:15
18:15
18:30
18:30
18:45
18:45
19:00
19:00
19:15
38
– Marrakech
/ 24-26 March 2016
**ARLAR
LunchCongress
kindly sponsored
by
www.arlar.org
39
19:15
Thursday, 24 March 2016 / Jeudi 24 mars 2016
Thursday, 24 March 2016
08:30 – 10:20
Fès 1
Meet the Experts
08:30 –09:20
Spondylarthropathies: an update
Chair: Ouafa Mkinsi, Casablanca, Morocco
Speaker: Khalid Abdallah Alnaqbi, Al Ain, United Arab Emirates
09:30 – 10:20
Spondyloarthritis (SpA) diagnosis; update on management immunopathogenesis of AS
Chair: Latifa Tahiri, Salé, Morocco
Speaker: Bassel Elzorkany, Egypt
08:30 – 10:20
Fès 2
Meet the Experts
08:30 – 09:20
Protéines alimentaires et os
Chair: Abdellah El Maghraoui, Rabat, Morocco
Speaker: René Rizzoli, Geneva, Switzerland
09:30 – 10:20
Consommer des produits laitiers : un danger ?
Chair: Ihsane Hmamouchi, Rabat, Morocco
Speaker: Fadoua Allali, Salé, Morocco
09:30 – 10:30
Karam 2
Abstract Session : RA
Chair: Munther Khamashta, Dubai, United Arab Emirates
Chair: Wafae Rachidi, Casablanca, Morocco
O01
Plasma levels of soluble triggring receptor expressed on myeloid cells-1 (STREM-1) in
rheumatoid arthritis and its correlation with disease activity and tumour necrosis factor α
H. Esaily1, A.E.-S. El-Hewala2, S. Soliman1, E. Abd Allah1, E. Badr3
1
Menofia Faculty of Medicine, Physical Medicine, Rheumatology and Rehabilitation, Menofia,
Egypt, 2Zagazig Faculty of Medicine, Physical Medicine, Rheumatology and Rehabilitation,
Zagazig, Egypt, 3Menofia Faculty of Medicine, Clinical Biochemistry, Menofia, Egypt
O02
Foot neuropathy in rheumatoid arthritis patients: clinical, electrophysiological and ultrasound
studies
A. El-Shanawany
Menoufia University, Physical Medicine, Rheumatology, and Rehabilitation, Shiben El-Koom,
Egypt
O03
Lung in rheumatoid arthritis: clinical and high resolution computerized tomography study
S. Tharwat, D. Shahin, A. Farouk
Mansoura Faculty of Medicine, Internal Medicine (Rheumatology & Immunology), Mansoura,
Egypt
O04
Anterior atlantoaxial subluxation in rheumatoid arthritis: prevalence and predictive values
O. Akkar, J. Eddarami, L. Ichchou
Mohamed VI University Hospital, Oujda, Morocco
O05
The reasons for late presentation of patients with inflammatory arthritis to a rheumatologist
A. AlMarzooqi, R. Babiker, J. Al Saleh
Dubai Hospital, Rheumatology, Dubai, United Arab Emirates
40
www.arlar.org
41
ARLAR
O06
The use of rituximab in rheumatoid arthritis: about 55 patients
F. Awassi, I. Kona Kaut, J. Essouiri, S. Driouach, A. Mounir, F.E. Abourazzak, T. Harzy
Sidi Mohammed Ben Abdallah University, Faculty of Medicine and Pharmacy of Fez, C.H.U.
Hassan II, Department of Rheumatology, Fez, Morocco
09:00 – 10:30
Reda 2
Ultrasound
Echographie débutants / intermédiaires: Echographie de l’épaule
Speaker: Noufissa Lazrak, Rabat, Morocco
Speaker: Ahmed Bezza, Rabat, Morocco
09:00 – 10:30
Reda 4
Ultrasound
Echographie débutants / intermédiaires : Echographie du genou
Speaker: Samy Slimani, Batna, Algeria
10:20 – 10:45
COFFEE BREAK
10:45 – 12:15
Salle des Ministres
Plenary Lectures / Plénières
Plenary Lecture 1
Chair: Najia Hajjaj-Hassouni, Rabat, Morocco
Chair: Radouane Niamane, Marrakech, Morocco
10:45 – 11:15
PL01
Management of co-morbidities associated with rheumatoid arthritis – practical aspects
Speaker: Boulos Haraoui, Montreal, Canada
42
11:15 – 11:45
PL02
Spondyloarthritis update on pathogenesis, diagnosis and management
Speaker: Maxime Dougados, Paris, France
ARLAR
11:45 – 12:15
PL03
State of the art in RA management
Speaker: Josef Smolen, Vienna, Austria
12:20 – 13:20
Salle des Ministres
Symposium Pfizer : see page 110
14:15 – 15:45
Salle des Ministres
Plenary Lecture 2
Chair: Philippe Gaudin, Grenoble, France
Chair: Khalid Abdallah Alnaqbi, Al Ain, United Arab Emirates
14:15 – 14:45
PL04
Osteoarthritis and obesity: an association more complex than expected
Speaker: Francis Berenbaum, Paris, France
14:45 – 15:15
PL05
Ultrasound practice in rheumatology
Speaker: Rachid Bahiri, Rabat-Salé, Morocco
15:15 – 15:45
PL06
Why gout must be treated
Speaker: Eliseo Pascual Gomez, Spain
www.arlar.org
43
15:45 – 16:15
Selected abstracts for plenary session 2 / Sélection de résumés pour la séance plénière 2
Chair: Philippe Gaudin, Grenoble, France
Chair: Khalid Abdallah Alnaqbi, Al Ain, United Arab Emirates
O13
The association between TNF-α promoter polymorphisms and ankylosing spondylitis in
Morocco
I. El Mouraghi1, A. Ouarour1, C. Kekik2, B. Polat2, F. Oguz2, I. Ghozlani3, A. El Maghraoui3
1
University Abdelmalek Essaidi, Faculty of Sciences, Department of Biology, Tétouan, Morocco,
2
Istanbul Medical Faculty, Medical Biology Department, Istanbul, Turkey, 3Military Hospital
Mohammed V, Rheumatology Department, Rabat, Morocco
O14
Rheumatoid arthritis management: rheumatologists practice modalities in Morocco
M. Ghazi, R. Niamane
Military Hospital Avicenne, Rheumatology, Marrakesh, Morocco
O15
Obese patients with RA have a more seropositive and a more active disease: results from the
KRRD registry
A. Al-Herz1, A. Al-Awadhi2, K. Saleh3, W. Al-Kandari3, E. Hasan1, A. Ghanem4, F. Abutiban5, A.
Alenizi5, M. Hussain1, Y. Ali4, A. Khadrawy3, A. Fazal3, K. Mokaddem1, B. Aftab5, N. Haider5, A.
Zaman4, G. Mazloum4, Y. Bartella1, S. Hamed1, A. Al-Saber6
1
Amiri Hospital, Rheumatology, Kuwait, Kuwait, 2Faculty of Medicine, Kuwait University,
Department of Medicine, Kuwait, Kuwait, 3Farwania Hospital, Rheumatology, Farwania,
Kuwait, 4Mubarak Al-Kabeer Hospital, Rheumatology, Hawally, Kuwait, 5Jahra Hospital,
Rheumatology, Jahra, Kuwait, 6Kuwait Technical College, Department of Mathematics, Kuwait,
Kuwait
14:15 – 16:05
Fès 1
Meet the Experts
ARLAR
14:15 – 15:05
Management of comorbidities in rheumatoid arthritis
Chair: Hani Almoallim, Jeddah, Saudi Arabia
Speaker: Maxime Dougados, Paris, France
15:15 – 16:05
Dose tapering of biologic agents in rheumatoid arthritis
Chair: Samy Slimani, Batna, Algeria
Speaker: Boulos Haraoui, Montreal, Canada
14:15 – 16:05
Fès 2
Meet the Experts
14:15 – 15:05
Les traitements des spondyloarthrites après échec des anti-TNF
Chair: Rafic Baddoura, Beirut, Lebanon
Speaker: Ouafa Mkinsi, Casablanca, Morocco
15:15 – 16:05
Treat to target dans la spondylarthrite ankylosante
Chair: Radouane Niamane, Marrakech, Morocco
Speaker: Mongi Touzi, Tunisia
14:45 – 16:05
Karam 2
Abstract session: AS
Chair: Ghita Harifi, Dubai, United Arab Emirates
Chair: Btissam. Hamdaoui, Morocco
44
www.arlar.org
45
O07
HLA –B27 in ankylosing spondylitis in the residents of the UAE: the 2015 version
H. Al Attia
Universal Hospital, Internal Medicine and Rheumatology, Abu Dhabi, United Arab Emirates
O08
Renal involvment in spondyloarthritis
S. Bouden, O. Saidane, I. Mahmoud, R. Tekaya, L. Aabdelmoula
Hopital Charles Nicolle, Tunis, Tunisia
O09
Axial spondyloarthritis and cigarette smoking
I. Kona Kaut1, J. Essouiri1, A. Romaric1, D. Diakite2, F.E. Abourazzak1, T. Harzy1
1
Sidi Mohammed Ben Abdellah University, Faculty of Medicine and Pharmacy of Fez, C.H.U.
Hassan II, Rheumatology, Fes, Morocco, 2Sidi Mohammed Ben Abdellah University, Faculty of
Medicine and Pharmacy of Fez, C.H.U. Hassan II, Epidemiology Unit, Fes, Morocco
O10
Prevalence and patterns of fibromyalgia in a cohort of patients with spondyloarthritis
A. Haddouche1, S. Haid2, S. Slimani3, A. Ladjouze2
1
Blida University, Medecine, Blida, Algeria, 2Medicine Faculty of Algiers, Algiers, Algeria,
3
Batna University, Batna, Algeria
O11
Subclinical enthesopathy in psoriatic patients and its relation to other disease parameters: a
power doppler ultrasonographic study
W. Gouda1, M. I. Abdel Kareem1, A. Mosalam1, A. Moshrif1
1
Al-Azhar University, Rheumatology and Rehabilitation, Assiut, Egypt
O12
Pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis
A. Majjad, F.E. Bertin, A. Mounach, S. Sadni, H. Toufiq, A. El Maghraoui
University Mohammed V, Rheumatology, Military Hospital Mohammed V, Rabat, Morocco
46
16:05 – 16:30
ARLAR
COFFEE BREAK
16:30 – 17:30
Salle des Ministres
Symposium AbbVie: see page 111
17:45 – 19:45
Salle des Ministres
Opening Session / Séance Inaugurale
www.arlar.org
47
Friday, 25 March 2016 / Vendredi 25 mars 2016
08:30 – 09:20
Fès 1
Meet the Experts
O18
Determining early referral criteria for patients with inflammatory arthritis presenting to
primary care physicians
H. Almoallim1, N. Janoudi2, S. Attar3, H. Alosaimi4, M. Garout5, M.I. Sidiqi1, A. Kamil6, S.
Alghohari6, A. Badokhon7
1
Umm Alqura Uiniversity, Makkah, Saudi Arabia, 2Dr. Soliman Fakeeh Hospital, Jeddah, Saudi
Arabia, 3King Abdulaziz University, Jeddah, Saudi Arabia, 4King Fahad Armed Forces Hospital,
Jeddah, Saudi Arabia, 5umm Alqura Uiniversity, Makkah, Saudi Arabia, 6Alzaidi Chair of
Research in Rheumatic Diseases, Makkah, Saudi Arabia, 7Ministry of Health, Jeddah, Saudi
Arabia
O21
comorbidities in the gout
M. Braham1, M. Jguirim2, M. Touzi2, A. Mhenni2, S. Zrour2, M. Younes3, I. Bejia2, N. Bergaoui2
1
CHU Fattouma Bourguiba Monastir, Rheumatology, Monastir, Tunisia, 2CHU Fattouma
Bourguiba Monastir, Monastir, Tunisia, 3CHU Taher Sfar Mahdia, Mahdia, Tunisia
08:30 – 09:20
Inflammatory myopathies
Chair: TBD
Speaker: Khader Mustafa, Amman, Jordan
08:30 – 10:20
Fès 2
Meet the Experts
Friday, 25 March 2016
08:30 – 09:20
Les acides hyaluroniques en pratique
Chair: Selma El Hassani, Morocco
Speaker: Emmanuel Maheu, Paris, France
09:00 – 10:20
Karam 1
Abstract Session: Miscellaneous
Chair: Meriem Fourtassi, Oujda, Morocco
Chair: Boubker Sedrati, Rabat, Morocco
O17
Metabolic syndrome in systemic lupus erythematosus and its associated factors: a crosssectional analysis
N. Hammam1, A.M. Rashed2, S.M. Rashad3
1
Assiut University Hospital, Rheumatology and Rehabilitation, Assiut, Egypt, 2Assiut University
/ Assiut University Hospitals, Assiut, Egypt, 3Assiut University / Assiut University Hospitals,
Rheumatology and Rehabilitation, Assiut, Egypt
08:30 – 10:20
Karam 2
Pediatric rheumatology - Session I
Chair: Adel M. Alwahadneh, Jordan
Chair: Noufissa Lazrak, Rabat, Morocco
08:30 – 09:00
Recent recommendations for auto-inflammatory diseases
Speaker: Marco Gattorno, Genova, Italy
09:00 – 09:30
Is So-JIA an autoinflammatory disease?
Speaker: Sulaiman Al-Mayouf, Riyadh, Saudi Arabia
09:30 – 10:00
Pediatric rheumatology in Arab countries: where we have been and where we are going?
Speaker: Samira Rostom, Rabat,, Morocco
10:00 – 10:20
Discussion
48
www.arlar.org
09:30 – 10:20
PRP en rhumatologie: Efficacité et controverse
Chair: Lahcen Achemlal, Morocco
Speaker: Fadoua Allali, Salé, Morocco
49
ARLAR
09:00 – 10:30
Reda 2
Ultrasound
US beginners / intermediates: Knee ultrasound
09:00 – 10:30
Reda 4
Ultrasound
US beginners / intermediates: ankle Ultrasound
Speaker: Ghita Harifi, Dubai, United Arab Emirates
10:20 – 10:45 COFFEE BREAK
10:45 – 12:15
Salle des Ambassadeurs
Plenary Lecture 3
Chair: Fadoua Allali, Salé, Morocco
11:45 – 12:15
PL08
Glucocorticoid induced osteoporosis
Speaker: Christian Roux, Paris, France
10:45 – 12:15
Fès 1
Parallel Session 1
Chair: Jamal Al Saleh, United Arab Emirates
Chair: Khader Mustafa, Amman, Jordan
10:45 – 11:15
Rheumatoid arthritis, past and present: the Moroccan experience
Speaker: Najia Hajjaj-Hassouni, Rabat-Salé, Morocco
11:15 – 11:45
RA registry in Qatar
Speaker: Samar Al-Emadi, Doha, Qatar
11:45 – 12:15
Where are we in biologic therapy and registry?
Speaker: Manal Al Mashaleh, Amman, Jordan
10:45 – 11:15
PL09
Fat, muscle, osteoporosis and inflammation
Speaker: Abdellah El Maghraoui, Rabat, Morocco
11:15 – 11:45
PL07
Vitamin D: where do we stand?
Speaker: René Rizzoli, Geneva, Switzerland
10:45 – 12:15
Karam 2
Pediatric rheumatology - Session II
Chair: Sulaiman Al-Mayouf, Riyadh, Saudi Arabia
Chair: Samira Rostom, Salé, Morocco
10:45 – 11:15
Too many biologic agents? Treatment strategies in JIA
Speaker: Rolando Cimaz, Firenze, Italy
11:15 – 11:45
Vaccinations in pediatric rheumatology: Current developments
Speaker: Bouchra Amine, Rabat, Morocco
50
www.arlar.org
ARLAR
51
11:45 – 11:55
O22
Profile of juvenile-onset compared to adult-onset spondyloarthritis
J. Es Souiri1, F. Awassi1, N. Benaicha2, F.E. Abourazzakc1, T. Harzy1
1
CHU Hassan II, Rheumatology, Fez, Morocco, 2Faculté de Medecine et de Pharmacie de Fes,
Epidemiology, Fez, Morocco
11:55 – 12:05
O23
Juvenile dermatomyositis in Arab children: a multi-center retrospective analysis of disease
features and outcome
S. Al-Mayouf1, N. AlMutairi1, M. Muzaffer2, R. Shehata3, A. Alwahadneh4, R. Abdwani5, S.
Alabrawi6, M. Abushukair4, Z. Elhabahbeh4, A. Alsonbul1
1
King Faisal Sepcialist Hospital and Research Center, Riyadh, Saudi Arabia, 2King Abdulaziz
University, Jeddah, Saudi Arabia, 3Maternity Children Hospital, Jeddah, Saudi Arabia, 4King
Hussein Medical Center, Amman, Jordan, 5Qaboos University, Masqat, Oman, 6Royal Hospital,
Masqat, Oman
12:05 – 12:15
O24
Impact of antiphospholipid antibodies in children with lupus nephritis
S. Al-Mayouf1,2, A. AlSaleem1, T. Al-Hussain3, A. Al Sonbul1, H. AlMana3
1
King Faisal Specialist Hospital & Research Center, Pediatric Rheumatology, Riyadh, Saudi
Arabia, 2Alfaisal University, Riyadh, Saudi Arabia, 3King Faisal Sepcialist Hospital & Research
Center, Pathology and Laboratory Medicine, Riyadh, Saudi Arabia
10:45 – 12:15
Reda 2
Ultrasound
US beginners/ intermediate: wrist ultrasound
Speaker: Hanan Rkain, Rabat-Salé, Morocco
Speaker: Souad Aktaou, Rabat, rabat, Morocco
52
10:45 – 12:15
Reda 4
Ultrasound
Echographie intermediaire / avancé : Echographie abarticulaire: tendons méconnus Speaker: Latifa Tahiri, Salé, Morocco
Speaker: Fatima Ezzahra Abourazzak, Fez, Morocco
11:30 – 12:15
Fès 2
Symposium Roche: see page 112
14:00 – 16:15
Karam 2
Pediatric rheumatology - Session III Chair: Rolando Cimaz, Florence, Italy
Chair: Bouchra Amine, Rabat, Morocco
14:00 – 14:30
Treatment in autoinflammatory deseases
Speaker: Marco Gattorno, Genova, Italy
14:30 – 15:00
Raynaud’s phenomena and systemic scleroderma in children: update
Speaker: Adel Alwahadneh, Amman, Jordan
15:00 – 15:30
Musculoskeletal ultrasound in paediatric rheumatology
Speaker: Noufissa Lazrak, Rabat, Morocco
15:30 – 15:53
Case challenges: I
Speaker: Sulaiman Al-Mayouf, Riyadh, Saudi Arabia
15:53 – 16:15
Case challenges: II
Speaker: Samira Rostom, Salé, Morocco
www.arlar.org
ARLAR
53
14:15 – 15:45
Plenary Lecture 4 Chair: Saloua Larhrissi, Morocco
Chair: Francis Berenbaum, Paris, France
14:15 – 14:45
PL10
Rehabilitation of rotator cuff disease
Speaker: Meriem Fourtassi, Oujda, Morocco
14:45 – 15:15
PL11
Management of frozen shoulder in 2016
Speaker: Fatima Ezzahra Abourazzak, Fez, Morocco
15:15 – 15:45
PL12
Critical lecture of the osteoarthritis guidelines (ACR, AAOS, OARSI, ESCEO)
15:45 – 16:15
Selected Abstracts for plenary session 4 / Sélection de résumés pour la séance plénière 4
Chair: Saloua Larhrissi, Morocco
Chair: Francis Berenbaum, Paris, France
O31
Potential role of human cartilage glycoprotein 39 in radiological progression of
early knee osteoarthritis
S. Egaila1, O. El-Shaer2, W. Hassan1, E. Sayed3, M. Abd El-Aty3
1
Benha University, Rheumatology and Rehabilitation, Benha, Egypt, 2Benha University, Clincal
Pathology, Benha, Egypt, 3Benha University, Rheumatology, Benha, Egypt
O32
Morphometric study of Algerian hips: etiological study explaining the low prevalence
of hip osteoarthritis
S. Slimani1, A. Ladjouze-Rezig2, K. Testas3, I. Bencharif4, M. Boukredera5, R. Chiheub5
1
University of Batna 2, Batna, Algeria, 2University of Algiers 1, Algiers, Algeria, 3El Khroub
Public Hospital, Constantine, Algeria, 4University of Constantine 3, Constantine, Algeria,
5
Private Practice, Constantine, Algeria
O33
Bone mineral density and vitamin D deficiency study in Tunisia: epidemiological aspect
of 389 cases
L. Metoui, R. Dhahri, N. Boussetta, F. Laajii, B. Louzir, H. Sahli, I. Gharsallah, S. Sallami
Rabta Hospital, Rheumatology Department, Tunis, Tunisia
ARLAR
14:15 – 16:15
Fès 1
Parallel Session 2 Chair: Imane El Bouchti, Morocco
Chair: Salah Eddine Maaroufi, Morocco
14:15 – 14:45
Rituximab en 1ère intention - Expérience marocaine
Speaker: Radouane Niamane, Marrakech, Morocco
14:45 – 15:15
Manifestations rhumatologiques du diabète
Speaker: Mohamed Younes, Tunisia
15:15 – 15:45
Regards bibliométriques sur la production scientifique des principaux pays arabes
dans le domaine de la rhumatologie
Speaker: Mohammed Essadaoui, Rabat, Morocco
Speaker: Ihsane Hmamouchi, Rabat, Morocco
54
www.arlar.org
55
15:45 – 16:15
Apport du cinéma documentaire en rhumatologie: expérience d’un rhumatologue marocain
(Film: Prisonnier de la douleur)
Speaker: Bouchaid El Messaoudi, Khouribga, Morocco
14:15 – 16:05
Fès 2
Meet the Experts
14:15 – 15:05
Quizz Imagerie
Chair: Taoufik Harzy, Morocco
Speaker: Philippe Gaudin, Grenoble, France
15:05 – 16:20
Karam 1
Abstract Session: OA - bone
Chair: Rachid Bahiri, Rabat-Salé, Morocco
Chair: Houda Kadiri, Morocco
O25
Quadriceps weakness and osteoarthritis of the knee
L. Metoui, R. Dhahri, N. Boussetta, F. Laajii, B. Louzir, I. Gharsallah, S. Othmeni
Principal Military Hospital of Tunis, Internal Medicine, Tunis, Tunisia
O26
Serum undercarboxylated osteocalcin and bone mineral density in premenopausal rhumatoid
arthritis patients
E. Galbat1, A.E.S. El Hawala2, S. Soliman3, H. Eseily3, D. Abo El Elaa4
1
Menoufia Faculty of Medicine, Rheumatology and Rehabilitation, El Shohada, Egypt, 2Zagazig
Faculty of Medicine, Rheumatology and Rehabilitation, Zagazig, Egypt, 3Menoufia Faculty
of Medicine, Rheumatology and Rehabilitation, Shebin El Kom, Egypt, 4Menoufia Faculty of
Medicine, Clinical Pathology, Shebin El Kom, Egypt
15:15 – 16:05
Aspects échographiques de la goutte
Chair: Ahmed Bezza, Morocco
14:15 – 15:05
Karam 1
Meet the Expert
MRI Sacro-iliac joints and spine: pitfalls and differential diagnosis Chair: Rachid Bahiri, Rabat-Salé, Morocco
14:15 – 15:15
Reda 2
General Assembly ARLAR
56
O27
Bone marrow lesion in advanced osteoarthritis of the knees. Correlation study between
histopathological findings and structural damage
Y. Hussein, H. Bassiouni
El-Hussein University Hospital, Rheumatology, Cairo, Egypt
O28
Bone erosion and bone loss profile in rheumatoid arthritis: about 93 Moroccan patients
H. Azzouzi, O. Akkar, M. Lehraiki, L. Lehlou, L. Boutouala, L. Ichchou
O29
Evaluation of the achievement of a therapeutic target of < 60 mg/L in Algerian patients treated
for gout
B. Bengana2, S. Slimani1, K. Testas3, F. Rahal2, S. Lefkir2, M.M. Makhloufi1, A. Ladjouze-Rezig2
1
University of Batna 2, Batna, Algeria, 2University of Algiers 1, Algiers, Algeria, 3El Khroub
Public Hospital, Constantine, Algeria
www.arlar.org
57
ARLAR
ARLAR
O30
Reproducibility of body composition measurements using dual energy X-ray absorptiometry
S. Sadni1, M. Dehhaoui2, A. El Maghraoui1
1
Military Teaching Hospital Mohamed V, Rabat, Morocco, 2Hassan II Institute of Agronomy and
Veterinary, Rabat, Morocco
16:05 – 16:30
17:30 – 18:20
Karam 1
Meet the Expert
Challenging cases in rheumatology
Chair: Fatima Ezzahra Abourazzak, Fez, Morocco
COFFEE BREAK
17:30 – 18:30
Karam 2
Pediatric rheumatology - Session IV
Business meeting
16:30 – 17:30
Symposium Hikma: see page 113
17:30 – 18:30
General Assembly SMR
17:30 – 18:20
Fès 1
Meet the Expert
Actualités du traitement de l’ostéoporose
Chair: Mongi Touzi, Tunisia
Speaker: Christian Roux, Paris, France
17:30 – 18:20
Fès 2
Meet the Expert
Challenging cases in RA management
Chair: Adel Al-Awadhi, Kuwait
Speaker: Hani Almoallim, Jeddah, Saudi Arabia
58
www.arlar.org
59
ARLAR
Saturday, 26 March 2016 / Samedi 26 mars 2016
08:30 – 10:20
Fès 1
Meet the Experts
08:30 – 09:20
An interactive workshop on imaging in SPA with tips on how to read MRI in SPA and 2 or 3
interactive case studies
Chair: Ouafa Mkinsi, Casablanca, Morocco
Speaker: Bassel Elzorkany, Cairo, Egypt
09:30 – 10:20
Disease activity assessment – assets and limitations
Chair: Samar Al-Emadi, Doha, Qatar
Speaker: Josef Smolen, Vienna, Austria
08:30 – 10:20
Karam 1
Meet the Experts 08:30 – 09:20
Gestion de la douleur neuropathique en pratique
Chair: Bouchra Amine, Rabat, Morocco
Speaker: Linda Ichchou, Oujda, Morocco
09:30 – 10:20
Evaluation de la qualité de vie en rhumatologie
Chair: Noufissa Lazrak, Rabat, Morocco
Speaker: Samira Rostom, Rabé-Salat, Morocco
08:30 – 09:20
Prise en charge de l’arthrose digitale
Chair: Hasna Hassikou, Meknes, Morocco
Saturday, 26 March 2016
09:30 – 10:20
La DXA en pratique
Chair: Saadia Janani, Casablanca Morocco
Speaker: Abdellah El Maghraoui, Rabat, Morocco
08:30 – 09:20
Reda 2
Meet the Expert
Management of crystal arthritis
Chair: Btissam Hamdaoui, Morroco
Speaker: Eliseo Pascual Gomez, Spain
09:00 – 10:30
Reda 4
Ultrasound
Echographie intermédiaires / avancés : Echograhie interventionnelle, principes et pratiques
Speaker: Philippe Gaudin, Grenoble, France
60
www.arlar.org
61
08:30 – 09:30
Karam 2
Workshop
Registry task force in RA (supported by Pfizer)
Speaker: Jamal Al Saleh, United Arab Emirates
08:30 – 10:20
Fès 2
Meet the Experts
09:30 – 10:30
Karam 2
Workshop
Registry task force in Lupus
Speaker: Munther Khamashta, Dubai, United Arab Emirates
10:20 – 10:45
COFFEE BREAK
10:45 – 12:15
Plenary Lecture 5
Chair: Manal Al Mashaleh, Amman, Jordan
Chair: Houda Kadiri, Morocco
10:45 – 11:15
Clinical significance of interleukin-23 and its receptor gene polymorphism in Behçets disease
Speaker: Tamer A. Gheita, Cairo, Egypt
11:15 – 11:45
Large vessel vasculitis (LVV)
Speaker: Khader Mustafa, Amman, Jordan
11:45 – 12:15
Acute rheumatic fever and poststreptococcal reactive arthritis: from infection to immune
disorders
Speaker: Najia Hajjaj-Hassouni, Rabat, Morocco
10:45 – 12:25
Fès 2
Meet the Experts
10:45 – 11:35
Challenging cases in rheumatology
11:35 – 12:25
La maladie de Behçet en 2016
Chair: Abdelkader Sarif, Morocco
Speaker: Zoubida Tazi, Rabat, Morocco
10:45 – 12:15
Reda 4
Ultrasound
Echographie intermédiaires / avancés : Echographie de la cheville
10:45 – 12:15
Karam 2
Workshop
Ultrasound training in rheumatology: sharing the experience in the Arabic world
Speaker: Waleed Alshehhi, United Arab Emirates
10:45 – 12:15
Reda 2
Ultrasound
Echographie intermédiaires / avancés : Echographie du coude
Speaker: Souad Aktaou, Rabat, rabat, Morocco
10:45 – 11:35
Fès 1
Meet the Expert
Evaluation du risque fractuaire par TBS
Chair: Hanan Rkain, Rabat-Salé, Morocco
Speaker: Hans Didier, Switzerland
62
ARLAR
www.arlar.org
63
12:20 – 13:20
Symposium Janssen: see page 114
14:15 – 16:15
Plenary Lecture 6
Chair: Marco Gattorno, Genova, Italy
Chair: Sulaiman Al-Mayouf, Riyadh, Saudi Arabia
14:15 – 14:45
Antiphospholipid syndrome
Speaker: Munther Khamashta, Dubai, United Arab Emirates
14:45 – 15:15
PL17
Lupus in 2016
Speaker: Zoubida Tazi, Rabat, Morocco
15:15 – 15:45
SLE and pregnancy
Speaker: Samar Al-Emadi, Doha, Qatar
15:45 – 16:15
Juvenile idiopathic arthritis: state of the art
Speaker: Rolando Cimaz, Firenze, Italy
14:15 – 16:15
Fès 1
Parallel Session
Parallel Session 3
Chair: Saadia Janani, Casablanca, Morocco
Chair: Samira Rostom, Salé, Morocco
64
14:15 – 14:45
Hépatites virales et biothérapies
Speaker: Wafae Rachidi, Casablanca, Morocco
14:45 – 15:15
Actualités du rhumatisme psoriasique
Speaker: Latifa Tahiri, Salé, Morocco
15:15 – 15:45
Marqueurs du remodelage osseux: quel intérêt dans la stratégie anti-ostéoporose?
Bone turnover markers: what is the interest in the anti-osteoporosis strategy?
Speaker: Kawter Nassar, Casablanca, Morocco
15:45 – 16:15
La monothérapie dans la PR
Speaker: Ouafa Mkinsi, Casablanca, Morocco
14:15 – 16:05
Karam 1
Meet the Experts
14:15 – 15:05
Examen du pied
Chair: Ahmed Bezza, Morocco
15:15 – 16:05
Rôle de la rééducation dans la prise en charges des lombalgies chroniques
Chair: Selma El Hassani, Morocco
Speaker: Meriem Fourtassi, Oujda, Morocco
16:05 – 16:30
www.arlar.org
ARLAR
COFFEE BREAK
65
ARLAR
Notes / Notes
16:30 – 17:20
Fès 1
Meet the Expert
Optimizing withrawal of therapy to sustain remission in RA
Chair: Saloua Larhrissi, Morroco
Speaker: Mohammed Hammoudeh, Doha, Qatar
16:30 – 17:20
Karam 1
Meet the Expert
Web based software to monitor RA, psoriatic arthritis and ankylosing spondylitis patients
Chair: Bassel El-Zorkany, Cairo, Egypt
16:30 – 17:20
Online tool for the management of rheumatoid arthritis, ankylosing spondylitis and
psoriatic arthritis in practice
Speaker: Rafic Baddoura, Beirut, Lebanon
16:30 – 17:30
Karam 2
Workshop
Workshop pregnancy in rheumatic diseases
66
www.arlar.org
67
ARLAR
Posters / Communications affichées
The poster authors are kindly asked to be present in front of their poster during the coffee
breaks
61
70
80
69 2
6
79 2
7
5
58 3
63
73
78
76
75
68
65
66
5
56 5
50
48
77 4
7
45
67 4
6
44
57 4
5
47
46
71
5
60 1
59 2
5
41
49 2
4
43
24
27
19
2
9
30 1
2
20 1
1
1
10
2
29 2
28 3
2
12
17
4
7
18 3
1
3
8
37 8
3
0
3 33 9 4 1
36 5 34
3
3 2
3
26 5
2
5
16 5
1
6
14
Les auteurs de posters sont priés de bien vouloir être presents devant leur poster pendant les
pauses café.
68
09:00 – 18:30
Salle Royale
Poster Session 1
P1.01
Biomarkers associated with increased risk of the presence of atherosclerosis in patients
with systemic lupus erythematosus and antiphospholipid syndrome
N. Khalil1, A. Badawi1, E. Darwish1, A. Abd Elhamid2, M. Wassef3
1
Cairo University, Internal Medicine and Immunology, Cairo, Egypt, 2Cairo University, Internal
Medicine and Vascular, Cairo, Egypt, 3Cairo University, Clinical Pathology, Cairo, Egypt
P1.02
The effect of ultraviolet ray exposure on DNA methylation in systemic lupus erythematosus
M. Zhang, X. Fang, G.-S. Wang, X.-P. Li
Anhui Provincial Hospital, Rheumatology and Immunology, Hefei, China
P1.03
Bone mineral density in systemic lupus erythematosus patients of multi ethnic background
C. Ventura, F. Kodah, H. Al-Mashari, R. Anuje, N. Abu Taha, K. Khawaja, M. Al Maini
Al Mafraq Hospital, Rheumatology/Paediatric, Rheumatology/Allergy/Immunology, Abu Dhabi,
P1.04
Correlation study of the expression of miR326 and Ets-1 in CD4+ T cells and the Th17 cells
on SLE patients
C. Dai, X. Li
Anhui Provincial Hospital, Hefei, China
P1.05
Would the body mass index influence the efficacy of tocilizumab in patients with rheumatoid
arthritis?
N. Bensaoud, S. Rostom, R. Bahiri, N. Hajjaj-Hassouni
Mohammed Vth University, Ibn Sina Universitary Hospitals, Department of Rheumatology,
El Ayachi Hospital, URAC30, Rabat, Morocco
www.arlar.org
69
ARLAR
P1.06
What are the motives for stopping the anti TNF α: a study of a series of 72 cases
Z. Alaya, D. Amri, S. Lataoui, E. Toulgui, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
Hospital Farhat HACHED, Rheumatology, Sousse, Tunisia
P1.07
Factors of good and bad response to anti-TNF alpha in rheumatoid arthritis
M. Bouzaouache, H. Zeglaoui, D. Amri, Z. Alaya, K. Baccouche, S. Belghali, E. Bouajina
CHU Farhat Hached, Rhumatology, Sousse, Tunisia
P1.08
The afficacy of infliximab plus methotrexate in patients with active rheumatoid arthritis in
north of Iraq: 5-year extended study
N. Barzinji
Hawler Medical University/College of Medicine, Medicine, Erbil, Iraq
P1.09
Not so benign skin rash in a patient of rheumatoid arthritis on infliximab
R. Aneja, H. Al Maashari, T. Khan, N. Abu-Taha, M. Al Maini
Mafraq Hospital, Rheumatology and Clinical Immunology, Abu Dhabi, United Arab Emirates
P1.10
Safety and efficacy of olokizumab in patients with moderate-to-severe rheumatoid arthritis
who have previously failed anti-TNF treatment: results from two open-label extension
studies
M. Genovese1, R. Fleischmann2, Y. Tanaka3, D. Furst4, H. Yamanaka5, R. Joshi6, W. Zhu7,
J. Shao8, A. Krotkova9, T. Takeuchi10
1
Stanford University Medical Center, Division of Immunology and Rheumatology, Stanford,
United States, 2University of Texas Southwestern Medical Center, Department of Medicine,
Dallas, United States, 3University of Occupational and Environmental Health, School of
Medicine, The First Department of Internal Medicine, Kitakyushu, Japan, 4University of
California Los Angeles, Department of Medicine, Los Angeles, United States, 5Tokyo Women’s
Medical University, Institute of Rheumatology, Tokyo, Japan, 6Quintiles Inc., Mumbai, India,
7
UCB Pharma, Raleigh, United States, 8UCB Pharma, Tokyo, Japan, 9R-Pharm, Moscow,
Russian Federation, 10Keio University, School of Medicine, Department of Internal Medicine,
Division of Rheumatology, Tokyo, Japan
P1.11
Efficacy and safety assessment of tocilizumab combined with improved disease-modifying
anti-rheumatic drugs on the refractory rheumatoid arthritis
M. Zhang, X.-P. Li
P1.12
Regression of rheumatoid nodules in patients with rheumatoid arthritis treated with
tocillizumab
H. Al Attia
Universal Hospital, Internal Medicine & Rheumatology, Abu Dhabi, United Arab Emirates
P1.13
Psoriasiform dermatitis following abatacept therapy for rheumatoid arthritis
H.S. Al Maashari1, T. Khan1, N. Abutaha1, R. Aneja1, K. Khawaja1, F. Abdul1, M. Hamodat2,
M. Al Maini1
1
Mafraq Hospital, Rheumatology, Abu Dhabi, United Arab Emirates, 2Sheikh Khalifa Medical
City, Pathology, Abu Dhabi, United Arab Emirates
P1.14
Rituximab place in rheumatology: about 23 cases
Z. Alaya, D. Amri, S. Lataoui, M.A. Souissi, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P1.15
Tofacitinib is feasible alternative to patients with rheumatoid arthritis in the Middle East
N. Ali Khan1, H. Hammoda2, M. ElSayed2, J. Al Saleh1
1
Dubai Hospital, Rheumatology, Dubai, United Arab Emirates, 2Hatta Hospital, Rheumatology,
Dubai, United Arab Emirates
P1.16
Clinical and laboratory characteristics of Lupus nephritis patients in a Tertiary care center in
Abu Dhabi
R. Aneja, H. Al Maashari, S. Gonuguntala, T. Khan, K. Al Khawaja, M. Al Maini
Mafraq Hospital, Rheumatology and Clinical Immunology, Abu Dhabi, United Arab Emirates
70
www.arlar.org
71
ARLAR
P1.17
Role of TGF-β1 in Egyptian systemic lupus erythematosus patients
M. El Menyawi, M. Wadie, M. Habib, H. Ahmed, O. Shaker
Cairo University, Department of Internal Medicine, Cairo, Egypt
P1.18
Secondary Sjögren´s syndrome in rheumatoid arthritis: characteristics and association with
joint damage
O. Akkar, L. Ichchou
P1.19
Systemic lupus erythematosus: clinical and therapeutic profile in rheumatology (about 78
cases)
Z. Alaya, M. Bouzaouache, S. Lataoui, M.A. Souissi, L. Mani, K. Baccouche, S. Belghali,
H. Zeglaoui, E. Bouajina
Hospital Farhat Hached, Rheumatology, Sousse, Tunisia
P1.20
Outcome of pregnancy in patients with systemic lupus erythematosus, prevalence of
maternal, obstetric, and fetal complications
H. Alkoky, N. Baghdadi, J. Al Saleh
P1.21
Early detection of asymptomatic pleuropulmonary manifestations in systemic lupus
erythematosus by high resolution CT and pulmonary function tests
S. Ghanem, M.M. Ghanem, M.A. Hegazy, E. Abo Elftouh, A. Negm, S. Daabous
Faculty of Medicine Alazhar University, Rheumatology, Rasheed, Egypt
P1.22
Systemic lupus erythematosus and fever
F. Belaziz, K. Nassar, W. Rachidi, S. Janani, O. Mkinsi
CHU Ibn Rochd, Rhumatologie, Casablanca, Morocco
P1.23
The use of Belimumab in lupus nephritis and trend of concordance with ESR and CRP
H.S. Al Maashari, T. Khan, N. Abu Taha, R. Aneja, K. Khawaja, F. Abdul, M. Al Maini
Mafraq Hospital, Rheumatology, Abu Dhabi, United Arab Emirates
P1.24
Baseline predictors of response of tumor necrosis factor-alpha blocking therapy in
ankylosing spondylitis
D. Amri, S. Belghali, M.A. Soussi, Z. Alaya, K. Baccouche, H. Zaglaoui, E. Bouagina
Farhat Hached Hospital, Rheumatology Department, Sousse, Tunisia
P1.25
Efficacy, tolerance and maintenance of adalimumab as first introduced biologic in patients
with spondyloarthritis in CHU Batna, Algeria.
S. Slimani, M.M. Makhloufi
University of Batna 2, Batna, Algeria
P1.26
Infliximab in the treatment of axial spondylarthritis: efficiency and tolerance
I. Kona Kaut, F.S. Awassi, A. Mounir, A. Romaric, F.E. Abourazzak, T. Harzy
Sidi Mohammed Ben Abdellah University, Faculty of Medicine and Pharmacy of Fez,
C.H.U. Hassan II, Rheumatology, Fes, Morocco
P1.27
The use of alternative medicine during the ankylosing spondylitis
S. Driouach, R. Angala, A. Mounir, F.E. Abourazzak, T. Harzy
Rheumatology, CHU Hassan II, Fez, Morocco
P1.28
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor
therapy using QuantiFERON-TB Gold test: the experience of MOHAMED VI university hospital
rheumatology departement
Y. Lemrhari, Z. Elhadrami, D. Jouida, I. El bouchti
Mohamed VI University Hospital, Marrakech, Morocco
72
www.arlar.org
73
ARLAR
P1.29
TNFα antagonist continuation rates in Tunisian spondyloarthrities patients with hip
involvement
K. Maatallah, I. Mahmoud, O. Saidane, A. Ben Tekaya, R. Tekaya, L. Abdelmoula
CHU Charles Nicolle, Rheumatology, Tunis, Tunisia
P1.30
Impact of switching tumor necrosis factor inhibitor in the spondyloarthritis
M.A. Souissi, Z. Alaya, S. Lataoui, E. Toulgui, L. Mani, K. Baccouche, S. Belghali, N. Amara,
I. Ben Smida, A. Jamel, H. Zeglaoui, E. Bouajina
Farhat Hached Hospital, Sousse, Tunisia
P1.31
Effectiveness of TNF alpha antagonists on coxitis during spondyloarthritis
M.A. Souissi, Z. Alaya, S. Lataoui, E. Toulgui, L. Mani, K. Baccouche, S. Belghali, N. Amara,
I. Ben Smida, A. Jamel, H. Zeglaoui, E. Bouajina
Farhat Hached Hospital, Sousse, Tunisia
P1.32
Axonal neuropathy with prolonged sulphasalazine use
J. Es Souiri, I. Kona, A. Mounir, F.E. Abourazzak, T. Harzy
CHU Hassan II, Rheumatology, Fez, Morocco
P1.33
characteristics of patients with ankylosing spondylitis in Qatar
F. Alam1, A.Q. Lutf2, N. Abdulla2, E.H.S. Elsayed2, M. Hammoudeh2
1
Hamad Medical Corporation, Rheumatology Internal Medicine, Doha, Qatar, 2Hamad Medical
Corporation, Internal Medicine, Doha, Qatar
P1.34
Smoking and ankylosing spondylitis: about 197 cases
M. Aouial, I. El Bouchti
University Hospital Mohammed VI, Rheumatology, Marrakech, Morocco
P1.35
Spondyloarthritis: a predictor of cardiovascular risk?
I. Henchiri, K. Ben Abdelghani, A. Fazaa, S. Kassab, S. Chekili, A. Lataar, L. Zakraoui
Hopital Mongi Slim, Rhumatology, Tunis, Tunisia
P1.36
Comorbidities and spondyloarthritis
N. Zehraoui, O. Cheikh, R. Atamane, R. Benaziez, F. Mechid, F. Hanni, C. Dahou-Makhloufi
Mohamed Lamine Debaghine University Hospital, Rheumatology, Algiers, Algeria
P1.37
Anthropometric measures impact on foot involvment among patients with spondyloarthritis
A. Ben Tekaya1, H. Sahli2, R. Tekaya1, I. Mahmoud1, O. Saidaine1, Y. Sedki1, L. Abdelmoula1
1
CHU Charles Nicolle, Rheumatology, Tunis, Tunisia, 2Rheumatology, Nabeul, Tunisia
P1.38
Markers of hip involvement during spondylarthropathy
University Hospital of Mohammed VI, Rhumatology, Marrakech, Morocco
P1.39
Bone mineral density in Tunisian patients with polyarticular juvenile idiopathic arthritis seen
in adulthood
A. Ben Tekaya, O. Saidane, I. Mahmoud, R. Tekaya, L. Abdelmoula
Charle Nicholle Hospital, Department of Rheumatology, Tunis, Tunisia
P1.40
Spondyloarthropathy and the phosphocalcic profiles
University Hospital of Mohammed VI, Rheumatology, Marrakech, Morocco
P1.41
Is there an association between spondyloarthritis radiographic features and foot
involvement?
A. Ben Tekaya, H. Sahli, R. Tekaya, I. Mahmoud, O. Saidane, Y. Sedki, L. Abdelmoula
Charle Nicholle Hospital, Rheumatology, Tunis, Tunisia
P1.42
Ankylosing spondylitis presenting with macrophage activation syndrome
F. Essafi, S. Kochbaty, F. Daoud, Z. Aydi, L. Baili, B. Ben Dhaou, F. Boussema
Habib Thamer Hospital, Tunis, Tunisia
74
www.arlar.org
75
ARLAR
P1.43
Distinctive features of female ankylosing spondylitis
S. Mostefai, N. Bahaz, S. Touazi, M. Benchennaf, N. Djekoun, M. Moussa Mebarek, S. Lefkir
Tafiani
University Hospital Centre Beni Messous, Rheumatology, Algiers, Algeria
P1.44
Comoparison between males and females with spondyloarthritis
J. Es Souiri1, N. Benaicha2, S. Driouach1, F.E. Abourazzak1, T. Harzy1
1
CHU Hassan II, Rheumatology, Fez, Morocco, 2CHU Hassan II, Epidemiology, Fez, Morocco
P1.45
Impact of foot involvement on disease status and life quality among patients with
spondyloarthritis
A. Ben Tekaya, H. Sahli, R. Tekaya, I. Mahmoud, O. Saidane, Y. Sedki, L. Abdelmoulah
Charle Nicholle Hospital, Rheumatology, Tunis, Tunisia
P1.46
The axial spondylitis and Still’s disease: a physiopathological link or a simple association?
About 3 cases
I. Kona Kaut, A. Mounir, N. Aradoini, F.E. Abourazzak, T. Harzy
Sidi Mohammed Ben Abdellah University, Faculty of Medicine and Pharmacy of Fez,
C.H.U. Hassan II, Rheumatology, Fes, Morocco
P1.47
Extra-intestinal manifestations during inflammatory bowel diseases: about 23 cases
Z. Alaya, L. Mani, S. Lataoui, M.A. Souissi, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P1.48
Influence of CRP and ESR on the activity and functional consequences of spondyloarthritis:
about 51 cases
S. Lataoui, Z. Alaya, N. El Amri, E. Toulgui, M.A. Souissi, L. Mani, K. Baccouche, S. Belghali,
H. Zeglaoui, E. Bouajina
P1.49
Heel pain characteristics when associated with spondyloarthritis
B.T. Aicha1, H. Sahli1, R. Tekaya1, I. Mahmoud1, O. Saifane1, Y. Sedki1, L. Abdelmoula2
1
Charle Nicholle Hospital, Rheumatology, Tunis, Tunisia, 2CHU Charles Nicolle, Rheumatology,
Tunis, Tunisia
P1.50
Clinical profile of spondyloarthritis
J. Es Souiri, I. Kona, R. Angala, F.E. Abourazzak, T. Harzy
CHU Hassan II, Rheumatology, Fez, Morocco
P1.51
The involvement of the anterior chest wall: about 12 cases
Z. Alaya, D. Amri, M. Bouzaouache, S. Lataoui, K. Baccouche, S. Belghali, H. Zeglaoui,
E. Bouajina
P1.52
Coexistence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis
I. Henchiri, D. Kaffel, W. Hamdi, M.M. Kchir
Institut Kassab, Rhumatology, Tunis, Tunisia
P1.53
Sonographic evaluation of entheseal involvement in patients with fibromyalgia
S. Abd El-Moniem1, S. Ganeb1, W. Hassan1, M. Mortada2, D. Gharib1
1
Benha University, Rheumatology and Rehabilitation, Benha, Egypt, 2Zagazig Faculty of
Medicine, Rheumatology and Rehabilitation, Zagazig, Egypt
P1.54
Are we equal in front of fibromyalgia according to our culture of acceptance of pain ?
A. Haddouche1, S. Slimani2
1
Blida University, Medicine, Blida, Algeria, 2Batna University, Medicine, Batna, Algeria
76
www.arlar.org
77
ARLAR
P1.55
Evaluation of vitamin D serum level in premenopausal Egyptian women with fibromyalgia
syndrome
I. Fawzy Ezz Mohammed1, M. Mohamed Al-Sayed1, H. Samy Nasser1, M. Kamal Abdel-Razek1,
M. Saeid Al-Shorbagy2
1
Al Azhar Faculty of Medicine, Rheumatology, Cairo, Egypt, 2Al Azhar Faculty of Medicine,
Clinical Pathology, Cairo, Egypt
P1.56
Correlation between Body mass index and lumbar spinal stenosis
L. Mani, Z. Alaya, S. Lataoui, M. Souissi, E. Toulgui, K. Baccouche, S. Belghali, H. Zeglaoui, E.
Bouajina
Farhet Hached Hospital, Rheumatology, Sousse, Tunisia
P1.57
Sleep quality and its determinants in patients with chronic neck pain
I. El Binoune1, B. Amine1, S. Shyen1, M. Erraoui1, J. Bahha1, S. Gueddari1, R. Abouqal2, N.
Hajjaj-Hassouni1
1
Mohammed V University, Faculty of Medicine and Pharmacy, LIRPOS, URAC 30, El Ayachi
Hospital, Rheumatology, Rabat-Sale, Morocco, 2Mohammed V University, Faculty of Medicine
and Pharmacy, Biostatistics, Rabat, Morocco
P1.58
Functional evaluation of the painful shoulder of women operated for breast cancer
M. Bouzaouache1, A. Jellad2, I. Bel Haj Youssef2, A. Nouira2, S. Salah2, H. Migaou2, S.
Boudokhane2, Z. Ben Salah2
1
CHU Farhat Hached, Rhumatology, Sousse, Tunisia, 2CHU Fatouma Bourguiba Monastir,
Physical Medicine, Monastir, Tunisia
P1.59
Effectiveness of acupuncture in variable medical disorders in a Tunisian center
S. Jemmali, B.A. Kawther, S. Kassab, N. El Amri, I. Abdelkafi, S. Chekili, A. Laatar, L. Zakraoui
Faculty of Medicine of Tunis, Mongi Slim Hospital, Rheumatology Department, Tunis, Tunisia
78
P1.60
Effect of accupuncture on cervicarthrosis in Tunisian patients
S. Jemmali, K. Ben Abdelghani, S. Kassab, I. Abdelkefi, S. Chekili, A. Laatar, L. Zakraoui
Faculty of Medicine, Mongi Slim Hospital, Rheumatology, Tunis, Tunisia
P1.61
Factors associated with the quality of life of patients with painful shoulder after surgery of
breast cancer
I. Bel Hadj Youssef, A. Jellad, M. Bouzawèche, H. Migaou, S. Boudoukhane, S. Salah, Z. Ben
Salah
CHU Fatouma Bourguiba Monastir, Service Medecine Physique et Réadaptation, Monastir,
Tunisia
P1.62
Effectiveness of acupuncture in cervicobrachial neuralgia in a Tunisian group
S. Jemmali, K. Ben Abdelghani, S. Kassab, N. El Amri, A. Imen, S. Chekili, A. Laatar, L.
Zakraoui
Faculty of Medecine of Tunis, Rheumatology, Tunis, Tunisia
P1.63
Presenteeism, work productivity in the patients with chronic neck pain
M. Erraoui1, B. Amine1, S. Shyen1, I. El Binoune1, J. Bahha1, S. Gueddari1, R. Abouqal2, N.
Hajjaj-Hassouni1
1
Mohammed V University, Faculty of Medicine and Pharmacy, LIRPOS, URAC 30, Rhumatology,
Rabat-Sale, Morocco, 2Mohammed V University, Faculty of Medicine and Pharmacy,
Biostatistics, Rabat, Morocco
P1.64
Management of brucellar spondylodiscitis in the Tunisian center: about 17 cases
Z. Alaya, D. Amri, S. Lataoui, L. Mani, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P1.65
Cervicobrachial neuralgia In Hospital Middle: about 482 cases
M. Aouial1, H. Arabi2, I. El Bouchti1, N. Kissani3
1
University Hospital Mohammed VI, Rheumatology, Marrakech, Morocco, 2Military Hospital
Avicenna, Physical Medicine, Marrakech, Morocco, 3University Hospital Mohammed VI,
Neurology, Marrakech, Morocco
www.arlar.org
79
ARLAR
P1.66
Cross-cultural adaptation and validation of the Copenhagen neck functional disability scale
(CNFDS) into Moroccan dialect Arabic in chronic neck pain patients
I. El Binoune1, B. Amine1, S. Gueddari1, M. Erraoui1, J. Bahha1, S. Shyen1, R. Abouqal2, N.
Hajjaj-Hassouni1
1
Mohammed V University, Faculty of Medicine and Pharmacy, LIRPOS, URAC 30/ El Ayachi
Hospital, Rheumatology, Rabat-Sale, Morocco, 2Mohammed V University, Faculty of Medicine
and Pharmacy, Biostatistics, Rabat, Morocco
P1.67
Fonctional disability and quality of life in patients with neck pain
J. Bahha1, B. Amine1, S. Gueddari1, I. Elbinoune1, M. Erraoui1, S. Shyen1, R. Abouqal2, N. HajjajHassouni1
1
University Mohammed V Souissi, URAC 30, Faculty of Medecine and Pharmacy,
Rheumatology, Sale, Morocco, 2University Mohammed V Souissi, URAC 30, Faculty of
Medecine and Pharmacy, Rabat, Morocco
P1.68
Common chronic neck pain in consultation of rheumatology: descriptive study
M. Erraoui, B. Amine, I. El Binoune, J. Bahha, N. Hajjaj-Hassouni
Mohammed V University, Faculty of Medicine and Pharmacy, LIRPOS, URAC 30, Rhumatology,
Rabat-Sale, Morocco
P1.69
Algodystrophy: about 60 cases
Z. Alaya, S. Lataoui, M.A. Souissi, D. Amri, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P1.70
Interventional ultrasound guided procedures for musculoskeletal pathology in physical
medicine and rehabilitation
I. Bel Haj Youssef1, S. Boudoukhane2, B. Ben Hmida3, H. Migaou2, A. Jellad1, M. Bouzawèche2,
S. Salah1, M. Golli4, Z. Ben Salah1
1
CHU Fatouma Bourguiba Monastir, Monastir, Tunisia, 2CHU Fatouma Bourguiba Moanstir,
Medecine Physique, Monastir, Tunisia, 3CHU Fatouma Bourguiba Moanstir, Radiologie,
Monastir, Tunisia, 4CHU Fatouma Bourguiba Monastir, Service de Radiologie, Monastir, Tunisia
80
P1.71
Surgical treatments of achilles tendon ruptures among sportsmen
H. Sahli1, S. Daas2, A. Ben Tekaya1, A. Khorbi2
1
Mohamed Taher Maamouri Hospital, Rheumatologic, Nabeul, Tunisia, 2Mohamed Taher
Maamouri Hospital, Orthopedic, Nabeul, Tunisia
P1.72
Persistent high levels of serum ferritin: a sharp sword to predict the occurrence of delayed
liver damage in patients with adult-onset Still´s disease
M. Zhang, X.-P. Li
P1.73
The interest of DENTASCAN in Multiple myeloma
M. Braham1, M. Jguirim1, M. Touzi1, D. Chaabouni2, S. Zrour1, M. Younes3, I. Bejia1, N. Bergaoui1
1
Bourguiba Monastir, Stomatological Departement, Monastir, Tunisia, 3CHU Taher Sfar,
Mahdia, Tunisia
P1.74
Autologous hematopoietic stem cell transplantation for multiple myeloma: review of 52
cases
D. Amri1, S. Belghali1, Z. Kmira2, M. Bouzaouach1, Z. Alaya1, K. Baccouche1, H. Zaglaoui1, E.
Bouagina1
1
Farhat Hached Hospital, Rheumatology, Sousse, Tunisia, 2Farhat Hached Hospital,
Haematology, Sousse, Tunisia
P1.75
Cleidocranial dysplasia: a family report
I. Gharsallah, R. Dhahri, N. Boussetta, F. Laajii, B. Louzir, L. Metoui, S. Othmeni
P1.76
Acroparesthesia? Think of Fabry disease!
I. Gharsallah1, R. Dhahri1, N. Boussetta2, F. Laajii1, B. Louzir1, L. Metoui2, S. Othmeni1
1
Principal Military Hospital of Tunis, Internal Medicine, Tunis, Tunisia, 2Principal Military
Hospital of Tunis, Tunis, Tunisia
www.arlar.org
81
ARLAR
P1.77
The outcome of renal amyloidosis secondary to inflammatory rheumatism: about 09 cases
J. Alhiane, S. Janani, K. Nassar, W. Rachidi, O. Mkinsi
Ibn Rochd Hospital, Rheumatology, Casablanca, Morocco
P1.78
Biphosphonates related osteonecrosis of the jaws ( BRONJ) among patients treated for
multiple myeloma (MM)
M. Braham1, M. Jguirim1, M. Touzi1, D. Chaabouni1, S. Zrour1, M. Younes2, I. Bejia1, N. Bergaoui1
1
CHU Fattouma Bourguiba Monastir, Rheumatology, Monastir, Tunisia, 2CHU Taher Sfar
Mahdia, Rheumatology, Mahdia, Tunisia
P1.79
Pseudo-rheumatoid dysplasia
I. Gharsallah1, R. Dhahri2, F. Laajii2, N. Boussetta2, B. Louzir2, L. Metoui2, S. Othmeni1
1
Principal Military Hospital of Tunis, Internal Medicine, Tunis, Tunisia, 2Principal Military
Hospital of Tunis, Tunis, Tunisia
82
09:00 – 18:30
Salle Royale
Poster Session 2
P2.01
Prevalence of depression among inflammatory arthritis (IA) patients living in the Middle East
D. Al Khamis, H. Basdsha
American School of Dubai, Al Barsha Dubai, United Arab Emirates
P2.02
Pulmonary manifestations in systemic sleroderma
S. Bouden, O. Saidane, I. Mahmoud, R. Tekaya, L. Abdelmoula
Hopital Charles Nicolle, Tunis, Tunisia
P2.03
The influencing factors in bone loss in rheumatoid arthritis (RA)
M. Braham1, M. Jguirim2, M. Touzi2, A. Mhenni2, S. Zrour2, M. Younes2, I. Bejia2, N. Bergaoui2
1
Bourguiba Monastir, Monastir, Tunisia
P2.04
Prevalence and risk factors for lung disease in rheumatoid arthritis
L. Lehlou, L. Ichchou
P2.05
Prevalence of comorbidities in patients with rheumatoid arthritis
A. Majjad, H. Toufiq, A. Majjad, S. Sadni, A. Mounach, A. El Maghraoui
P2.06
Rheumatoid arthritis and comorbidities
R. Benaziez1, F. Mechid2, N. Zehraoui2, C. Dahou-Makhloufi2
1
Mohammed Lamine Debaghine Hospital, Medecine, Rheumatology, Bab El Oued, Algeria,
2
Mohammed Lamine Debaghine Hospital, Rheumatology, Bab El Oued, Algeria
www.arlar.org
83
ARLAR
P2.07
Ocular surface abnormalities and disease activity in rheumatoid arthritis
N. Hammam1, Z. Eldaly2
1
Assiut University / Assiut University Hospitals, Rheumatology and Rehabilitation Department,
Assiut, Egypt, 2Assiut University / Assiut University Hospitals, Ophthalmology Department,
Assiut, Egypt
P2.08
Vitamin D status and its association with disease activity, severity and physical disability in
rheumatoid arthritis patients
O. Akkar, L. Ichchou
P2.09
Prevalence and risk factors for ophthalmological manifestations in rheumatoid arthritis
L. Lehlou, B. Alami, O. Akkar, R. Sekhsoukh, L. Ichchou
P2.10
Immunological status in rheumatoid arthritis: association with disease parameters and
osteoporosis
L. Lehlou, L. Boutouala, L. Ichchou
P2.11
Neuropathic pain in patients with rheumatoid arthritis: a cross-sectional study
O. Akkar, M. Lehraiki, H. Azzouzi, L. Boutouala, L. Ichchou
P2.12
Prevalence of low bone mass in patient with early inflammatory arthritis presenting to early
arthritis clinic
A. Almarzooqi, J. Al Saleh
84
P2.13
Cardiovascular parameters in rheumatoid arthritis: about 70 Moroccan patients
H. Azzouzi1, L. Ichchou2
1
Mohamed VI University Hospital, Rheumatology, Oujda, Morocco, 2Mohammed VI University
Hospital, Rheumatology, Oujda, Morocco
P2.14
Prevalence of depression in rheumatoid arthritis in the eastern region of Morrocco: about 83
patients
M. Lehraiki, H. Azzouzi, L. Boutouala, O. Akkar, L. Ichchou
P2.15
Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted
SCORE algorithms
F. Essafi1, K. Abdelghani2, Fezaa.A , Kassab.S , Chkili.S , Laatar.A ,Zakraoui .L
1
Monji Slim Hospital, Rhumatology, Sidi Daoud, Marsa, Tunisia, 2Monji Slim Hospital, Marsa,
Tunisia
P2.16
Audit of influenza and pneumococcal vaccination in patients with rheumatoid arthritis
J. Teir1, K. Al Nagbi1, N. Al Hassani2
1
Al Ain Hospital, Rheumatology, Al Ain, United Arab Emirates, 2Al Ain Hospital, Al Ain, United
Arab Emirates
P2.17
Oral STATE in rheumatoid arthritis
M. Braham1, M. Jguirim1, M. Touzi1, D. Chaabouni2, A. Mhenni2, M. Younes3, S. Zrour2, I. Bejia2,
N. Bergaoui2
1
Bourguiba Monastir, Monastir, Tunisia, 3CHU Taher Sfar Mahdia, Mahdia, Tunisia
P2.18
Study of ocular manifestations associated with rheumatic diseases among Egyptian patients
M. Abdelkareem1, H. Hegazy2
1
Al-Azher Faculty of Medicine, Rheumatology, Cairo, Egypt, 2Al-Azher Faculty of Medicine,
Ophthalmology, Cairo, Egypt
www.arlar.org
85
ARLAR
P2.19
Profile of vitamin D in patients with rheumatoid arthritis
R. Farah, D. Jouida, I. El Bouchti
Mohamed VI University Hospital, Marrakech, Morocco
P2.20
Bone mineral density in adult patients with inflammatory arthropathy
A. Tayseer, N. Abu Taha, K. Khawaja, M. Al Maini
P2.21
Does screening for tuberculosis before initiation of anti-TNFα therapy influence treatment choice?
S. Lataoui, S. Belghali, N. El Amri, K. Baccouche, D. Amri, Z. Alaya, H. Zeglaoui, E. Bouajina
P2.22
Characteristics of patients with systemic sclerosis in Qatar
F. Alam1, S. Al Emadi1, I.U. Haq2, H.A. Abdulaziz1
1
Hamad Medical Corporation, Rheumatology Internal Medicine, Doha, Qatar, 2Hamad Medical
Corporation, Internal Medicine, Doha, Qatar
P2.23
Inflammatory myopathies in rheumatology: about 13 cases
Z. Alaya, S. Lataoui, M. Bouzaouache, E. Toulgui, K. Baccouche, S. Belghali, H. Zeglaoui, E.
Bouajina
P2.24
Idiopathic snapping scapula syndrome: about one case
I. Kona Kaut, F.S. Awassi, J. Essouiri, L. Tahiri, F.E. Abourazzak, T. Harzy
Sidi Mohammed Ben Abdellah University, Faculty of Medicine and Pharmacy of Fez, C.H.U.
Hassan II, Rheumatology, Fes, Morocco
P2.25
Osteoporosis in inflammatory bowel desease
S. Najim, K. Nassar, W. Rachidi, S. Janani, O. Mkinsi
Ibn Rochd University Hospital, Rheumatology, Casablanca, Morocco
P2.26
The risk of osteoporotic fractures according to the FRAX model in rheumatoid arthritis
patients in Slemani Province
R. Merza
University of Slemani, College of Medicine, Slemani, Iraq
P2.27
Preliminary comparison between normative spine TBS data for Moroccan men and women
S. Sadni1,2, D. Tran3, R. Winzenrieth3, A. Mounach1,2, A. El Maghraoui1,2
1
Military Hospital Mohammed V, Rheumatology Department, Rabat, Morocco, 2University
Mohammed V, Souissi, Morocco, 3Med-Imaps, R & D Department, Bordeaux, France
P2.28
Osteoporosis prevalence and associated factors in patients with chronic obstructive pulmonary
disease
D. Amri1, Z. Alaya1, R. Zorgui2, K. Baccouche1, S. Belghali1, H. Zaglaoui1, E. Bouagina1
1
Farhat Hached Hospital, Rheumatology Department, Sousse, Tunisia, 2CHU Hached,
Pneumology, Sousse, Tunisia
P2.29
Osteodensitometric and metabolic profile in male hypogonadism
N. Bouznad1, G. El Mghari1, A. Belkhou2, I. El Bouchti2, N. El Ansari1
1
Laboratory PCIM, FMPM, University Hospital Mohamed VI, Department of Endocrinology,
Diabetes, Metabolic Diseases and Nutrition, Marrakech, Morocco, 2University Hospital
Mohamed VI, Department of Rheumatology, Marrakech, Morocco
P2.30
Patients’ experiences and their knowledge of osteoporotic disease: preliminary study
A. Yahyaoui1, K. Ben Abdelghani2, A. Fezaa2, S. Kassab2, A. Laatar2
1
Monji Slim Hospital, Rheumatology Department, Tunis, Tunisia, 2Mongi Slim Hospital, Tunis,
Tunisia
86
www.arlar.org
P2.31
Reproducibility of bone mineral density measurements using dual X-ray absorptiometry
L. Lehlou, N. Abda, L. Ichchou
87
ARLAR
P2.32
Abstract has been withdrawn by author
P2.33
Clinical features and densitometry data of patients treated for breast cancer
S. Lataoui, S. Belghali, K. Baccouche, M.A. Souissi, N. El Amri, Z. Alaya, N. Amara, H.
Zeglaoui, E. Bouajina
P2.34
Interest of osteoporosis IOF risk test
M. Chammakhi, K. Ben Abdelghani, A. Fazaa, S. Kassab, S. Chekili, A. Lataar, L. Zakraoui
Faculty of Medicine of Tunis, Tunis, Tunisia
P2.35
SubnormaI versus normal ionized calcium levels in patients with hypovitaminosis D
H. Al Attia
Universal Hospital, Internal Medicine & Rheumatology, Abu Dhabi, United Arab Emirates
P2.36
Epidemiology and clinical features of osteoporotic patients treated with risedronate and
treatment compliance
S. Belghali, E. Toulgui, S. Lataoui, K. Baccouche, L. Mani, N. El Amri, Z. Alaya, H. Zeglaoui, E.
Bouajina
P2.37
Obesity: a protective factor against osteoporosis?
A. Bahlous1,2, M. M’Rad1,2, E. Kalaie2, S. Bahri1, H. Sahli2, K. Bouzid3, J. Abdelmoula3
1
Institut Pasteur of Tunis, University of Tunis El Manar, Clinical Chemistry Laboratory, Tunis,
Tunisia, 2Research Laboratory ‘Immuno-Rhumatologie’ (LR05SP01), Tunis, Tunisia, 3Charles
Nicolle Hospital, Clinical Chemistry Laboratory, Tunis, Tunisia
P2.38
Endocrindocrinopathies and bone repercussions
N. Bouznad1, G. El Mghari2, A. Belkou3, I. El Bouchti3, N. El Ansari2
1
CHU Mohamed VI, Service d’Endocrinologie, Marrakech, Morocco, 2Laboratory PCIM,
FMPM, University Hospital Mohamed VI, Department of Endocrinology, Diabetes, Metabolic
Diseases and Nutrition, Marrakech, Morocco, 3University Hospital Mohamed VI, Department of
Rheumatology, Marrakech, Morocco
P2.39
Rare forms of osteoporosis
H. Al Attia
Universal Hospital, Internal Medicine & Rheumatology, AbuDhabi, United Arab Emirates
P2.40
Frax determination in a cohort of tunisian patients
P2.41
Evaluation of daily calcium intake in a population of tunisian patients
M. Chammakhi, K. Ben Abdelghani, M. Slouma, A. Fazaa, S. Kassab, S. Chekili, A. Lataar, L.
Zakraoui
P2.42
Our experience in treatment with Zoledronic Acid in postmenopausal women with osteoporosis
P2.43
Cross-cultural adaptation and validation of the screen for child anxiety related disorders test
(SCARED) in juvenile idiopathic arthritis
H. Tazi Lachhab, S. Rostom, B. Amine, R. Bahiri, N. Hajjaj Hassouni
Mohammed Vth University, URAC 30, Faculty of Medicine and Pharmacy , Rabat, Morocco,
Department of Rheumatology, Rabat, Morocco
88
www.arlar.org
89
ARLAR
P2.44
P2.45
Impact of side effects of Methotrexate treatment on psychology and quality of life of children
with juvenile idiopathic arthritis
Mohammed Vth University, URAC 30, Faculty of Medicine and Pharmacy, Department of
Rheumatology, Rabat, Morocco
P2.46
Cross-cultural adaptation and validation of the children depression rating scale test (CDRS)
in juvenile idiopathic arthritis
Mohammed Vth University, URAC 30, Faculty of Medicine and Pharmacy , Rabat, Morocco,
P2.47
A locally modified protocol in the management of non-infectious uveitis in pediatric
rheumatology clinic: a successful common language rheumatology-ophthalmology practice
M. Abushukair, A. Alwahadneh, Z. Habahbeh, R. Alzyood, M. Almutereen, M. Alswaty, H. Ben
Dahman, H. Algrainy
King Hussein Medical Center, Pediatric Rheumatology, Aidun, Jordan
P2.48
Access to care for juvenile idiopathic arthritis to paediatric rheumatology subspecialty in the
K. Khawaja, M. Al Maini
P2.49
Osteoporosis among children with chronic diseases (Early detection and causes)
A. Fahmy
Alazhar University, Rheumatology, Cairo, Egypt
P2.50
The pattern of juvenile idiopathic arthritis in a single tertiary center in Saudi Arabia
M. Alhemiari
Ministry of Health, Pediatric, Jeddah, Saudi Arabia
P2.51
Juvenile idiopathic arthritis in central Tunisia: about 54 cases
Z. Alaya, N. El Amri, S. Lataoui, E. Toulgui, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P2.52
Hip involvement in juvenile idiopathic arthritis: a study of 54 cases
S. Lataoui, Z. Alaya, N. El Amri, E. Toulgui, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P2.53
Efficacy of yttrium-90 radiosynovectomy in camptodactyly-arthropathy-coxa vara-pericarditis
syndrome
N. AlMutairi1, K. Alismail2, S. Al-Mayouf3,4
1
King Faisal Specialist Hospital and Research Center, Pediatric Rheumatology, Riyadh, Saudi
Arabia, 2King Faisal Sepcialist Hospital and Research Center, Musculoskeletal Radiology,
Riyadh, Saudi Arabia, 3King Faisal Specialist Hospital and Research Center, Riyadh, Saudi
Arabia, 4Alfaisal University, Riyadh, Saudi Arabia
P2.54
sport activity in Tunisian patients with idiopathic juvenile arthritis
K. Maatallah, K. Ben Abdelghani, A. Fazaa, S. Miladi, S. Kassab, A. Laatar
Mongi Slim Hospital, Rheumathology, Tunis, Tunisia
P2.55
Is joint injections with triamccinolone hexa acetonide useful if the management of progressive
pseudo rheumatoid arthropathy of childhood?
K. Khawaja, M. Al Maini
90
www.arlar.org
91
ARLAR
P2.56
Detection of ultrasonographic changes of pes anserine syndrome secondary to primary knee
osteoarthritis before and after local corticosteroid injection
M. Gamal, S. Elaraby, E. Abdelaziem, M. Abouelaila, A. Fathy
Alazhar University Hospital, Rheumatology, Cairo, Egypt
P2.57
Interest of bone turnover markers in hemodialysis patients
M. M’Rad1,2, A. Bahlous1,2, E. Kalaie2, M. Bouksila2, S. Bahri1, M. Slouma2, J. Abdelmoulla3,
H. Sahli2
1
Tunisia, 2Research Laboratory ‘Immuno-Rhumatologie’ (LR05SP01), Tunis, Tunisia, 3Charles
Nicolle Hospital, Clinical Chemistry Laboratory, Tunis, Tunisia
P2.58
Osteoarticular manifestations resulting from treatment with anti-aromatase
R. Angalla1, H. Azzouzi2, A. Mounir1, F.Z. Abourazzak1, T. Harzy1
1
CHU Hassan II, Service de Rhumatologie, Fès, Morocco, 2CHU Mohammed VI, Service de
Rhumatologie, Oujda, Morocco
P2.59
Ultrasonography and power Doppler ultrasonography of knee joint in patients with hepatitis
C virus related arthritis
R. Elgohary1, A. Khalil2, G. Ragab2
1
Kasr Alainy Medical School, Internal Medicine, Cairo, Egypt, 2Kasr Alainy Medical School,
Cairo, Egypt
P2.60
Clinical, etiologic and progressive profile of chronic monoarthritis
R. Alaya, S. Rekik, S. Boussaid, R. Ben Saad, E. Cheour, H. Sahli, M. Elleuch
CHU la Rabta, Department of Rhumatologie, Tunis, Tunisia
P2.61
A comparison of rheumatoid arthritis patients in Kuwait with other populations: results from
the KRRD registry
A. Al-Herz1, A. Al-Awadhi2, K. Saleh3, W. Al-Kandari3, E. Hasan1, A. Ghanem4, F. Abutiban5, A.
Alenizi5, M. Hussain1, Y. Ali4, A. Khadrawy3, A. Fazal3, K. Mokaddem1, B. Aftab5, N. Haider5, A.
Zaman4, G. Mazloum4, Y. Bartella1, S. Hamed1, A. Al-Saber6
Department of Medicine, Kuwait, Kuwait, 3Farwania Hospital, Rheumatology, Farwania,
Kuwait, 4Mubarak Al-Kabeer Hospital, Rheumatology, Hawally, Kuwait, 5Jahra Hospital,
Rheumatology, Jahra, Kuwait, 6Kuwait Technical College, Department of Mathematics, Kuwait,
Kuwait
P2.62
Le coût annuel de la prise en charge de la polyarthrite rhumatoïde avec le méthotrexate et le
rituximab
G. Afantchao1, L. Benbrahim2,3, B. Benchekroun2,3, H. Rkain2,3, F. Allali2,3, B. Amine2,3, S.
Rostom2,3, R. Bahiri2,3, S. Ahid1,2,4, N. et Hajjaj-Hassouni2,3
1
Université Mohammed V, Faculté de médecine et de pharmacie de Rabat, Equipe de
recherche Pharmacoépidémiologie & Pharmacoéconomie, Rabat, Morocco, 2Université
Mohammed V, Laboratoire d’information et de recherche sur la pathologie osseuse. Faculté
de médecine et de pharmacie de Rabat. URAC 30, Rabat, Morocco, 3Centre hospitalier Ibn
Sina, Service de Rhumatologie. Hôpital El Ayachi, Rabat, Morocco, 4Hôpital El Ayachi, Centre
hospitalier Ibn Sina, Service de Pharmacie hospitalière, Rabat, Morocco
P2.63
What is the fastest route for patients with inflammatory arthritis to early arthritis clinic?
A. AlMarzooqi, J. Al Saleh
P2.64
Pattern of psoriatic arthritis in 56 Egyptian adults
A. Negm, S. AL Araby, E. Abdulazim, M. Abul Ela, A. AboGamal
Al Azhar Faculty of Medicine, Rheumatology, PM & Rehab, Nasr City, Egypt
P2.65
Specifications of musculoskeletal disorders in diabetic patients: a cohort study
H. Toufiq, A. Majjad, A. Mounach, S. Maataoui, L. Abainou, S. Sadni, A. El Maghraoui
University Mohammed V, Rabat, Morocco
P2.66
Rheumatology research in Morocco: a bibliometric study using Scopus database
K. El Bairi, H. Azzouzi, L. Ichchou
92
www.arlar.org
1
93
ARLAR
P2.67
Norm references of fat-free mass index and fat mass index in Moroccan adults aged from 20
to 80 years
S. Sadni1, M. Dehhaoui2, A. El Maghraoui1
1
Military Teaching Hospital Mohamed V, Rabat, Morocco, 2Hassan II institute of Agronomy and
Veterinary, Rabat, Morocco
P2.68
Musculoskeletal disorders in diabetes mellitus patients in a physical medicine and
rehabilitation department
S. Salah, M. Rekik, I. Belhaj Youssef, S. Boudokhane, A. Jellad, Z. Ben Salah Frih
Faculty of Medicine of Monastir, Physical Medicine and Rehabilitation, Monastir, Tunisia
P2.69
Impact of marital status on parameters of rheumatoid arthritis
O. Akkar, L. Boutouala, H. Azzouzi, M. Lehraiki, L. Ichchou
P2.70
Vitamin D status among women living in a sunny region in Morocco - Marrakesh
S. Baki, I. Harkati, A. Tali, G. Elmghari, L. Chabaa, N. El Ansari
University Hospital Mohammed VI, Marrakech, Morocco
P2.71
Steroid use in rheumatoid arthritis: about 112 patients
M. Lehraiki, H. Azzouzi, L. Ichchou
P2.72
Effectiveness of ultrasound guided caudal epidural steroid injection in pain relief and
improvement of electrophysiological parameters in patients with chronic radicular low back
pain
M. Emad Abd-El-Fattah1, M. Awadalla1, A. Sayed Omar1, M. Elshatory2
1
Suez Canal University, Physical Medicine, Rheumatology and Rehabilitation, Ismailia, Egypt,
2
Suez Canal University, Radiology, Ismailia, Egypt
P2.73
The study of the effect of hyperosmolar dextrose solution local intra-articular injections for
frozen shoulder treatment: a randomized clinical trial
A. Beltagi, A. Ramadan, A. Omar
Suez Canal University, Rheumatology, Physical Medicine and Rehabilitation, Ismailia, Egypt
P2.74
Camptocormia: management in rehabilitation medicine
I. Bel Hadj Youssef1, S. Boudoukhane1, H. Migaou1, M. Bouzawèche2, S. Salah1, A. Jellad1,
Z. Ben salah1
1
CHU Fattouma Bourguiba Monastir, Monastir, Tunisia, 2CHU Fatouma Bourguiba Monastir,
Medecine Physique, Monastir, Tunisia
P2.75
Idiopathic static spinal disorders in children and adolescents in physical medicine and
rehabilitation department
S. Salah, M. Bouzaouech, A. Nouira, H. Migaou, A. Jellad, Z. Ben Salah Frih
Faculty of Medicine of Monastir, Physical Medicine and Rehabilitation, Monastir, Tunisia
P2.76
Disease Bessel-Hagen or multiple exostosis functional impact for which support PMR?
Z. Boukara, K. Safai, K. Daoued, A.C. Nouar
Saad Dahleb University, Medicine, Blida, Algeria
P2.77
Quality of life in a sample of Tunisian patient with spinal cord injury
H. Migaou1, I. Bel Hadj Youssef2, S. Boudoukhane1, M. Bouzawèche1, S. Salah2, A. Jellad1,
Z. Ben Salah2
1
CHU Fatouma Bourguiba Monastir, Medecine Physique, Monastir, Tunisia, 2CHU Fatouma
Bourguiba Monastir, Monastir, Tunisia
P2.78
The confidence of pediatric residents in performing musculoskeletal screening examination
in children
R. Al Ani1, K. Khawaja2, M. Al Maini2
1
Al Mafraq Hospital, Pediatrics, Abu Dhabi, United Arab Emirates, 2Al Mafraq Hospital,
Rheumatology, Abu Dhabi, United Arab Emirates
94
www.arlar.org
95
ARLAR
09:00 – 18:30
Salle Royale
Poster Session 3
P3.01
P3.02
Progressive pseudorheumatoid dysplasia: orthopedic manifestations and challenges of care
I. Bel Hadj Youssef, S. Jemni, S. Froui, A. Zaoui, F. Khachnaoui
CHU Sahloul, Physical Medecine and Rehabilitation, Sousse, Tunisia
P3.03
Peripheral blood T helper 17 cells and serum interleukin 17 in rheumatoid arthritis patients:
relation to disease activity
E. Baraka1, G. Abdel Ghafar1, M. El Behecy2, D. El Ghwas3
1
Benha University, Rheumatology and Rehabilitation, Benha, Egypt, 2Benha University, Clinical
Pathology, Benha, Egypt, 3Benha Teaching Hospital, Rheumatology and Rehabilitation, Benha,
Egypt
P3.04
IgG4 related disease with sclerosing bone disease: a diagnostic dilemma
F. Abdul, H. Saeed Al Maashari, T. Khan, R. Aneja, K. walid Khawaja, N. Ibrahim Abu Taha,
Q. Rustum, M. Al Maini
MAFRAQ Hospital, Rheumatology, Abu Dhabi, United Arab Emirates
P3.05
The frequency of allergy in patients with Behçet’s disease
G. Keskin1, A. Inal2, M. Yildiz3, G. Duman4
1
Medical School of Ankara University, Immunology, Ankara, Turkey, 2GATA, Immunology,
Ankara, Turkey, 3DYBEAH, Internal Medicine, Ankara, Turkey, 4DYBEAH, Immunology, Ankara,
Turkey
96
P3.06
Study of IL-33 level as a marker of disease activity in human systemic lupus erythematosus
(SLE)
H. Mosbeh, A.Y. El Shanbaky, E.A. Said, E.R. Abdel Gwad
Benha University, Benha, Egypt
P3.07
Serum and synovial granulocyte colony stimulating factor (G-CSF) levels as markers of
disease activity and severity in rheumatoid arthritis
E. Baraka1, N. Fouad2
1
Benha University, Rheumatology and Rehabilitation, Benha, Egypt, 2Benha, Microbiology and
Immunology, Benha, Egypt
P3.08
Serum CXCL13 concentrations in patients with systemic lupus erythematosus and its
correlation to disease activity and lupus nephritis
A. Abdalla1, S. Egaila1, R. El-Tanawy1, E. Baraka1, M. El-Bhissy2
1
Benha University, Rheumatology and Rehabilitation, Benha, Egypt, 2Batna University, Clinical
and Chemical Pathology, Benha, Egypt
P3.09
Effect of fish oil supplements on susceptibility of low-density lipoprotein to oxidation in
female patients with rheumatoid arthritis
N. Rashtchizadeh, A. Ghorbanihaghjo, A. Khabazi, M. Hajialilo, M.R. Jafari Nakhjavani,
S. Kolahi
Connective Tissue Disorders Research Center, Tabriz University of Medical Sciences, Tabriz,
Iran, Islamic Republic of
P3.10
Adverse events of biotherapy: rheumatology department experience (During 2010-2015)
J. Alhiane, S. Janani, K. Nassar, W. Rachidi, O. Mkinsi
Ibn Rochd Hospital, Rheumatology, Casablanca, Morocco
P3.11
Lipoprotein (a) and homocysteine in rheumatoid arthritis patients
A. Ghorbanihaghjo, N. Rashtchizadeh, M. Hajialilo, A. Khabazi, M.R. Jafari Nakhjavani, S. Kolahi
Connective Tissue Disorders Research Center, Tabriz University of Medical Sciences, Tabriz,
Iran, Islamic Republic of
www.arlar.org
97
ARLAR
P3.12
Relating bone marrow oedema to hs-CRP in knee osteoarthritis
H. Aly
Al Azhar University Faculty of Medicine, Rheumatology, Physical Medicine and Rehabilitation,
Cairo, Egypt
P3.13
Probing the relation between vitamin D deficiency and progression of medial femoro - tibial
osteoarthitis of the knee
H. Aly
Al-Azhar University, Rheumatology, Cairo, Egypt
P3.14
Serum sclerostin levels in rheumatoid arthritis
A. Abdelsalam
Ain Saams, Cairo, Egypt
P3.15
Correlation between synovitis assessed by ultrasonography and the bone edema on
dedicated magnetic resonance imaging (MRI) in patients with rheumatoid arthritis
L. Bouhouche, S. Rostom, H. Rkain, N. Bensaoud, R. Bahiri, N. Hajjaj-Hassouni
Mohammed Vth University, URAC 30, Faculty of Medicine and Pharmacy, El Ayachi Hospital,
P3.16
Concordance between clinical examination and ultrasound in rheumatoid arthritis
S. Miladi1, I. Zouch1, D. Kaffel1, A. Aouadi1, W. Hamdi1, M. Chelli2, M. Kchir1
1
Institut Kassab of Orthopedics, Rheumatology, Tunis, Tunisia, 2Institut Kassab of Orthopedics,
Radiology, Tunis, Tunisia
P3.17
Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease
S. Miladi1, W. Hamdi1, D. Kaffel1, I. Zouch1, M. Chelli2, M. Kchir1
1
P3.18
Concordance between synovitis on ultrasonography and dedicated magnetic resonance
imaging (MRI) during rheumatoid arthritis
L. Bouhouche, S. Rostom, H. Rkain, N. Bensaoud, R. Bahiri, N. Hajjaj-Hassouni
Mohammed Vth University, URAC 30, Faculty of Medicine and Pharmacy, El Ayachi Hospital,
P3.19
Evaluation of a simplified version of the rheumatoid arthritis magnetic resonance imaging
score (RAMRIS) reduced to 5 joints (RAMRIS5)
N. Bensaoud, S. Rostom, R. Bahiri, N. Hajjaj-Hassouni
Mohammed Vth University, Ibn Sina Universitary Hospitals, Department of Rheumatology,
El Ayachi Hospital, URAC30, Rabat, Morocco
P3.20
Correlation between the disease activity and immunological laboratory tests in the
rheumatoid arthritis
K. Baccouche, L. Mani, S. Belghali, Z. Alaya, H. Zeglaoui, E. Bouajina
P3.21
Anti-cyclic citrullined peptide and ultrasound activity in rheumatoid arthritis
S. Miladi1, W. Hamdi1, I. Zouch1, D. Kaffel1, M. Chelli2, M. Kchir1
1
P3.22
Interest of protein profile in rheumatoid arthritis
A. Bahlous1,2, M. M’rad1,2, E. Kalaie2, S. Bahri1, S. Ben Ammar1
1
Tunisia, 2Research Laboratory ‘Immuno-Rhumatologie’ (LR05SP01), Tunis, Tunisia
P3.23
Efficiency of clinical examination in detecting tenosynovitis in rheumatoid arthritis
S. Miladi1, I. Zouch1, W. Hamdi1, K. Maatallah1, D. Kaffel1, M. Chelli2, M. Kchir1
1
98
www.arlar.org
99
ARLAR
P3.24
Rheumatoid arthritis and marital status
R. Ben Saad, S. Rekik, S. Boussaid, R. Alaya, H. Sahli, I. Cheour, M. Elleuch, H. Ajleni
La Rabta, Tunis, Tunisia
P3.25
Correlation of rheumatoid arthritis activity indexes (Disease Activity Score, Simplified
Disease Activity Index and Clinical Disease Activity Index): a Tunisian experience
F. Essafi, K. Abdelghani, S. Kassab, A. Fezaa, S. Chkili, A. Laatar, L. Zakraoui
Monji Slim Hospital, Rhumatology, Sidi Daoud, Tunisia
P3.26
The immunological markers of rheumatoid arthritis
J. Es Souiri1, R. Angala2, O.D. Diakite3, A. Mounir1, F.E. Abourazzak1, T. Harzy1
1
CHU Hassan II, Rheumatology, Fez, Morocco, 2CHU Hassan II, Fez, Morocco, 3Faculté de
Medecine et de Pharmacie de Fes, Epidemiology, Fez, Morocco
P3.27
Ultrasonography applications in diagnosis and management of early rheumatoid arthritis
I. Henchiri, D. Kaffel, W. Hamdi, M.M. Kchir
Institut Kassab, Rhumatology, Tunis, Tunisia
P3.28
Quality of life assessment in Moroccan rheumatoid arthritis patients: relation to clinical
features and disease activity
L. Boutouala, O. Akkar, L. Lehlou, H. Azzouzi, M. Lehraiki, L. Ichchou
P3.29
Diagnosis of arthritis in the elderly: about 133 cases
S. Lataoui, Z. Alaya, L. Mani, M.A. Souissi, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P3.30
Involvement of the hip in rheumatoid arthritis patients: sonographic assessment
M. Wabi, B. Amine, F. Moussa El Ibrahim, S. Aktaou, N. Hajjaj-Hassouni
Faculty of Medicine and Pharmacy, University Mohammed V - LIRPOS - URAC30, Service of
Rheumatology, El Ayachi Hospital, CHU, Rabat, Morocco
P3.31
Comparison of radiographic and ultrasound data in detecting erosions in rheumatoid
arthritis
N. El Amri1, S. Belghali1, M. Limame2, S. Lataoui1, K. Baccouche1, Z. Alaya1, H. Zeglaoui1,
E. Bouajina1
1
Farhat Hached Hospital, Rheumatology Department, Sousse, Tunisia, 2Farhat Hached
Hospital, Radiology Department, Sousse, Tunisia
P3.32
P3.33
Which joints of the hands should we target by ultrasound examination to detect erosions?
N. El Amri1, M. Limame2, S. Belghali1, S. Lataoui1, K. Baccouche1, Z. Alaya1, H. Zeglaoui1, E.
Bouajina1
1
P3.34
Are aortic calcifications associated with bone mineral density, vertebral fractures or disease
activity in patients with rheumatoid arthritis?
A. Majjad, A. Mounach, S. Sadni, H. Toufiq, A. El Maghraoui
P3.35
Relationship between sleep disorders and quality of Life in patients with rheumatoid
arthritis
L. Boutouala, O. Akkar, L. Lehlou, H. Azzouzi, M. Lehraiki, L. Ichchou
P3.36
Comparison of clinical examination and ultrasound findings in rheumatoid arthritis
S. Belghali1, N. El Amri1, M. Limame2, S. Lataoui1, K. Baccouche1, D. Amri1, Z. Alaya1, N.
Amara1, H. Zeglaoui1, E. Bouajina1
1
100
www.arlar.org
101
ARLAR
P3.37
Rheumatoid nodules rarely manifested in RA patients in Kuwait: results from the KRRD
registry
A. Al-Herz1, A. Al-Awadhi2, K. Saleh3, W. Al-Kandari3, E. Hasan1, A. Ghanem4, F. Abutiban5,
A. Alenizi5, M. Hussain1, Y. Ali4, A. Khadrawy3, A. Fazal3, K. Mokaddem1, B. Aftab5, N. Haider5,
A. Zaman4, G. Mazloum4, Y. Bartella1, S. Hamed1, A. Al-Saber6
1
Department of Medicine, Kuwait, Kuwait, 3Farwania Hospital, Rheumatology, Farwania, Kuwait,
4
Mubarak Al-Kabeer Hospital, Rheumatology, Hawally, Kuwait, 5Jahra Hospital, Rheumatology,
Jahra, Kuwait, 6Kuwait Technical College, Department of Mathematics, Kuwait, Kuwait
P3.38
Quality of life and psychological disorders in rheumatoid arthritis
L. Mani, K. Baccouche, Z. Alaya, S. Belghali, H. Zeglaoui, E. Bouajina
P3.39
Impact of body mass index on parameters of rheumatoid arthritis
O. Akkar, M. Lehraiki, H. Azzouzi, L. Boutouala, L. Ichchou
P3.40
Rheumatoid arthritis of men: a study of 56 cases in a Moroccan hospital
A. Mounir, S. Driouach, F.E. Abourazzak, T. Harzy
CHU Hassan II, Rheumatology, Fes, Morocco
P3.41
Fatigue in patients with rheumatoid arthritis: prevalence and association with disease
parameters
O. Akkar, L. Boutouala, H. Azzouzi, M. Lehraiki, L. Ichchou
P3.42
The incidence of anemia in rheumatoid arthritis
S. Ozbek
Cukurova University, Rheumatology, Adana, Turkey
P3.43
When fibromyalgia is associeted to rheumatoid arthritis
R. Ben Saad, R. Rekik, S. Boussaid, R. Alaya, H. Sahli, I. Cheour, M. Elleuch, H. Ajleni
La Rabta, Tunis, Tunisia
P3.44
Case of cholesterol crystal bursitis in rheumatoid arthritis
F. Awassi1, I. Kona Kaut1, A. Mounir1, L. Tahiri2, F.E. Abourazzak1, T. Harzy1
1
Sidi Mohammed Ben Abdallah University, Faculty of Medicine and Pharmacy of Fez,
C.H.U. Hassan II, Department of Rheumatology, Fez, Morocco, 2Mohammed V University
of Rabat / Faculty of Medicine and Pharmacy of Rabat / El Ayachi Hospital, Department of
Rheumatology, Rabat, Morocco
P3.45
A prospective study of glutamates of methotrexate and its efficacy
A. Sandhu1,2, V. Dhir2, A. Bhatnagar3, V. Dhawan4, J. Kaur5, A. Sood4
1
Panjab University, Chandigarh, India, 2PGIMER, Internal Medicine, Chandigarh, India, 3Panjab
University, Biochemistry, Chandigarh, India, 4PGIMER, Chandigarh, India, 5GMCH Sec 32,
Chandigarh, India
P3.46
Methotrexate in rheumatoid arthritis. Tolerance and maintenance in real life conditions in
Algerians
S. Slimani1, I. Bencharif2
1
University of Batna 2, Batna, Algeria, 2University of Constantine 3, Constantine, Algeria
P3.47
Is the use of analgesics in patients with rheumatoid arthritis related to the intensity of pain,
inflammation or disability?
L. Lehlou, O. Akkar, L. Ichchou
P3.48
Description of the prescribing practices of steroids at the Mohamed VI university hospital of Oujda
M. Lehraiki, H. Azzouzi, L. Ichchou
102
www.arlar.org
103
ARLAR
P3.49
Anti-tumor necrosis factor-alpha therapy in refractory Behçet uveitis: a single center
experience
Z. Yilmaz1,2, G. Keser2, S. Güven Yilmaz2, B. Sozeri2, H. Ates2, Gokhan Keser2, Suzan Güven
Yilmaz2, BetulSozeri2, Halil Ates2
1
Tepecik Training and Research Hospital, Rheumatology, Izmir, Turkey, 2Ege University School
of Medicine, Department of Internal Medicine Rheumatology, Izmir, Turkey
P3.50
Behcet disease: a case study
B. Bengana1, S. Azeli1, D. Fodil1, N. Brahimi2, A. Ladjouze2, S. Lefkir - Tafiani1
1
CHU Beni Messous, Rheumatology, Algiers, Algeria, 2EHS Benaknoun, Rheumatology,
Algiers, Algeria
P3.51
Mediastinal fibrosis combined with Behcet´s disease: five case reports
I. Gharsallah, R. Dhahri, N. Boussetta, F. Laajii, B. Louzir, L. Metoui, S. Othmeni
P3.52
Epidemiological, clinical and radiological profile of psoriatic arthritis in the rheumatology
department at CHU HASSAN II FES
F. Awassi1, J. Essouiri1, R. Angala1, I. Kona Kaut1, B.M. Traoré2, F.E. Abourazzak1, T. Harzy1
1
Sidi Mohammed Ben Abdallah University, Faculty of Medicine and Pharmacy of Fez,
C.H.U. Hassan II, Department of Rheumatology, Fez, Morocco, 2Sidi Mohammed Ben Abdallah
University, Faculty of Medicine and Pharmacy of Fez, C.H.U. Hassan II, Epidémiologie, Fez,
Morocco
P3.53
Association of synovitis versus cartilage loss with pain severity and functional limitation in
primary osteoarthritis: clinical, ultrasonography and magnetic resonance imaging
A. Saad Abbas, M. Ismail Abdel Kareem, M. Abdelazeem Mahmoud
Alazhar University, Rheumatology, Assuit, Egypt
P3.54
Prevalence and determinants for neuropathic pain in knee osteoarthritis. An Algerian
multicenter study
K. Testas1, S. Slimani2, M. Abbas3, D. Kebaili4, R. Chiheub5
1
Elkhroub Hospital, Constantine, Algeria, 2Batna University, Batna, Algeria, 3Private
Rheumatologist, Msila, Algeria, 4Oum Bouagui Hospital, Oum Bouagui, Algeria, 5Private
Rheumatologist, Constantine, Algeria
P3.55
Neuropathic pain in knee osteoarthritis: is its prevalence related to a greater impact?
O. Akkar, L. Lehlou, L. Ichchou
P3.56
Role of intra articular injection of autologous platelet-rich plasma in primary knee
osteoarthritis
A. Ibrahim Hammad1, N. Abdel Salam El Kadery2, M. Aly Elwy2, E. Mahmoud Ghaniema2,
H. Moussa Sakr3
1
Faculty of Medicine Ain Shams University Cairo, Physical Medicine, Rheumatology and
Rehabilitation, Qualyobia, Egypt, 2Faculty of Medicine Ain Shams University Cairo, Physical
Medicine, Rheumatology and Rehabilitation, Cairo, Egypt, 3Faculty of Medicine Ain Shams
University Cairo, Radiodiagnosis, Cairo, Egypt
P3.57
Epidemiology of osteoarthritis in Algeria. A very low frequency of hip osteoarthritis
S. Slimani1, I. Bencharif2, A. Haddouche3, D. Bendjenna2, D. Kebaili4, T. Khaled5, S. Hermez6,
L. Djeghader7
1
University of Batna 2, Batna, Algeria, 2University of Constantine 3, Constantine, Algeria,
3
University of Blida, Blida, Algeria, 4Oum Bouagui Hospital, Oum El Bouagui, Algeria, 5Private
Practice, Constantine, Algeria, 6El Berrouaghia Hospital, Medea, Algeria, 7El Khroub Public
Hospital, Constantine, Algeria
P3.58
kinesiophobia and catastrophizing: relationship with pain and disability in patients with knee
osteoarthritis
D. Khnaba, S. Rostom, L. Bouhouche, N. Bensaoud, H. Tazi Lachhab, R. Bahiri, N. Hajjaj-Hassouni
Mohammed Vth University, Ibn Sina Universitary Hospitals, El Ayachi Hospital, Rheumatology,
Salé, Morocco
104
www.arlar.org
105
ARLAR
P3.59
Medical care of knee arthritis: a study of 60 cases
L. Metoui1, R. Dhahri1, N. Boussetta1, F. Laajii1, B. Louzir2, I. Gharsallah2, S. Othmeni2
1
Principal Military Hospital of Tunis, Tunis, Tunisia, 2Principal Military Hospital of Tunis,
Internal Medicine, Tunis, Tunisia
P3.60
Audit of osteoarthritis patient referral to dieticians and physiotherapy
J. Varghese, K. Khawaja, M. Al Maini
P3.61
Improved quality of life through tidal irrigation in advanced knee osteoarthritis
S. Mostefai1, D. Hannoune2, H. Djoudi3, S. Lefkir Tafiani1
1
University Hospital Centre Beni-Messous, Rheumatology, Algiers, Algeria, 2National Institute
of Public Health (INSP), Algiers, Algeria, 3University Blida, Rheumatology, Blida, Algeria
P3.62
Platelets rich plasma intra articular injections new & promising treatment option for knee
osteoarthritis
K. Al-Chalabi1,2
1
Neuro-Spinal Hospital, Dubai, United Arab Emirates, 2Royal Medical Center, Dubai, United
Arab Emirates
P3.63
Frequency of vitamin D inadequacy in young adults and early middle-aged males in Qassim
region
H. Fayed
Cairo University, Rheumatology, Cairo, Egypt
P3.64
Hyperuricemia and hypertension in Algerian population
B. Bengana1, B. Hachemi2, M. El Rakawi3, D. Fodil1, N. Bahaz1, S. Mostefai1, S. Lefkir-Tafiani1
1
CHU Beni Messous, Rheumatology, Algiers, Algeria, 2EPH Meftah, Internal Medicine, Blida,
Algeria, 3EHS Douera, Rheumatology, Blida, Algeria
P3.65
P3.66
Osteoarticular imaging findings in primary hyperparathyroidism
S. Lataoui, Z. Alaya, D. Amri, M.A. Souissi, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
P3.67
Brown tumor in chronic hemodialysis patients
L. Jawhari1, K. Nassar1, W. Rachidi1, S. Janani1, O. Mkinsi1, N. Belhadi2, N. Mtioui2, B. Ramdani2
1
Ibn Rochd Hospital University, Rheumatology, Casablanca, Morocco, 2Ibn Rochd Hospital
University, Nephrology, Casablanca, Morocco
P3.68
Unusual presentation of primary hyperparathyroidism: a report of three cases
S. Miladi, D. Kaffel, W. Hamdi, I. Zouch, M.M. Kchir
Institut Kassab of Orthopedics, Rheumatology, Tunis, Tunisia
P3.69
Paget´s disease of bone: clinical and therapeutic features
R. Alaya, Alaya Z, Zeglaoui H, Amri D, Baccouche K, Belghali S, Bouajina E
CHU Hached, Department of Rhumatologie, Sousse, Tunisia
P3.70
Paget’s disease of bone: therapeutic outcomes
I. Henchiri, S. Miladi, I. Zouch, W. Hamdi, D. Kaffel, M.M. Kchir
Institut Kassab of Orthopedics, Rhumatology, Tunis, Tunisia
P3.71
Persistent intercostal neuralgia: think to the disc calcification
H. Sahli1, A. Bachali2, R. Tekaya3, R. Amri4, K. Bouzaidi5
1
Mohamed Taher Maamouri Hospital, Rheumatologic, Nabeul, Tunisia, 2Mohamed Taher
Maamouri Hospital, Laboratory, Nabeul, Tunisia, 3Charles Nicolle Hospital, Rheumatologic,
Tunis, Tunisia, 4Mohamed Taher Maamouri Hospital, Medical Department, Nabeul, Tunisia,
5
Mohamed Taher Maamouri Hospital, Imaging, Nabeul, Tunisia
106
www.arlar.org
107
ARLAR
P3.72
Skeletal fluorosis - a case report from United Arab Emirates
R. Aneja1, J.M. Reddy2, H. Al Maashari1, T. Khan1, N. Abu-Taha1, M. Al Maini1
1
Mafraq Hospital, Rheumatology and Clinical Immunology, Abu Dhabi, United Arab Emirates,
2
Mafraq Hospital, Radiology, Abu Dhabi, United Arab Emirates
P3.73
Prevalence of viral hepatitis B and C in rheumatoid arthritis patients
M. Lehraiki, H. Azzouzi, L. Boutouala, O. Akkar, L. Ichchou
P3.74
Panorama of osteo-articular and soft tissues infections
R. Angalla, J. Essouri, I. Kona, L. Tahiri, F.Z. Abourazzak, T. Harzy
CHU Hassan II, Service de Rhumatologie, Fès, Morocco
P3.75
Evolutionary aspects of febrile acute arthritis
A. Ajrinija, Z. El Hadrami, M. Aouial, A. Belkhou, I. El Bouchti
University Hospital Mohammed VI, Rheumatology, Marrakech, Morocco
P3.76
Infectious spondylodiscitis: from diagnosis to treatment
R. Alaya, S. Rekik, S. Boussaid, R. Ben Saad, H. Ajlani, H. Sahli, E. Cheour, M. Elleuch
Rabta Hospital, Department of Rhumatologie, Tunis, Tunisia
P3.77
Contribution of imaging in the diagnosis of infectious spondylodiscitis: about 78 cases
S. Lataoui, Z. Alaya, N. El Amri, D. Amri, K. Baccouche, S. Belghali, H. Zeglaoui, E. Bouajina
108
Information about
Sponsors and Exhibitors
Informations sur les
sponsors et exposants
www.arlar.org
109
ARLAR
Satellite Symposia / Les Symposiums Satellites
Thursday, 24 March 2016 / Jeudi 24 mars 2016 Thursday, 24 March 2016 / Jeudi 24 mars 2016 12:20 – 13:30
Salle des Ministres
Pfizer Symposium
16:30 – 17:30
Salle des Ministres
AbbVie Symposium
12:20 – 12:25 Welcome
Dorsaf Essoussi, MD - Regional Therapeutic Area Lead, Pfizer Africa & Middle East
Beyond clinical symptoms in RA: The value of inhibiting progression & achieving
long Term Disease Control.
12:25 – 12:30
Introduction
Pr Najia Hajjaj-Hassouni, MD - Head of Rheumatology & Rehabilitation Department, El Ayachi universitary hospital, Salé, Morocco
12:30 – 13:00
“ENBREL in Spondyloarthritis: from the achievements to the
perspectives”
Pr Maxime Dougados, MD - Professor of Rheumatology, L’Université Paris
Descartes, Paris, France
13:00 – 13:15
Q&A
Pr Najia Hajjaj-Hassouni, MD - Head of Rheumatology & Rehabilitation
Department, El Ayachi universitary hospital, Salé, Morocco
13:15 – 13:20
Closing
Dorsaf Essoussi, MD - Regional Therapeutic Area Lead,
Pfizer Africa & Middle East
110
Faculty and Program:
Carlomaurizio Montecucco, MD
Professor of Rheumatology
Dean, University of Pavia School of Medicine
Symposium Chair:
Adel AL Awadhi
Professor of Rheumatology/ Faculty of Medicine - Kuwait University
www.arlar.org
111
ARLAR
Friday, 25 March 2016 / Vendredi 25 mars 2016 Friday, 25 March 2016 / Vendredi 25 mars 2016 11:30 – 12:15
Salle Fès 2
Roche Symposium
Chair: Rachid Bahiri, Rabat-Salé, Morocco
16:30 – 17:30
Hikma Symposium
Le MTX dans la vraie vie : utilisation et adhérence
Abdellah El Maghraoui, Rabat, Morocco
La gestion des effets secondaires du MTX autour de cas cliniques
112
16:30 – 16:40
Welcoming and Introduction
16:40 – 17:10
Remsima in Rheumatology
Tore Kvien, Oslo, Norway
17:10 – 17:30
Discussion
www.arlar.org
113
ARLAR
Notes / Notes
12:20 – 13:20
Janssen Symposium
Understanding the treatment landscape in rheumatology: from current practice to future
perspectives
Chair: Prof. Najia Hajjaj Hassouni, Morocco
Faculty: Prof Peter Taylor, UK
12:20-12:40
Chairs’ welcome and introduction to the programme
Prof. Najia Hajjaj Hassouni
12:40-13:15
Keynote lecture
What have we learned about optimizing responses to biologic TNF blockade in RA
Prof. Peter Taylor
13:15
Question and Answers / Closing Remarks
Prof. Najia Hajjaj-Hassouni (Morocco) and Prof. Taylor (UK)
114
www.arlar.org
115
ARLAR
The Exhibition / L’exposition
About our Sponsors / Nos partenaires se présentent
Level 0 / Niveau 0
Arlar thanks our sponsors and partners / ARLAR remercie nos sponsors et partenaires
Gold Sponsor
11
4
12
13
AbbVIe
On January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and
capabilities to address some of the world's greatest health challenges. AbbVie has the stability,
resources, expertise, and passion to discover, develop, and bring to market groundbreaking
science to solve the biggest health problems that face the world today and tomorrow.
3
5
Catering
Restauration
10
9
6
2
7
1
SOCIÉTÉ MAROCAINE
DE RHUMATOLOGIE
8
AFRIC-PHAR
AFRIC-PHAR is one of the leading economic players to have contributed to the development of
the Moroccan pharmaceutical market.
The company provides import, manufacturing, and distribution of pharmaceutical products
across a broad range of therapeutic classes
AFRIC-PHAR has made it its mission to provide the highest quality medicines at the lowest costs
for patients and healthcare professionals. The laboratory is committed to improving healthcare
development and health for people.
Salle Royale
Exhibitor
Booth
Exhibitor
Booth
Pfizer
1
Roche
8
Sothema
2
Amgen
9
Abbvie
3
Afric Phar
10
Janssen
4
Novartis
11
Sanofi
5
PHI
12
Hikma
6
Bottu
13
Cooper
7
116
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious
illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
This approach begins by using advanced human genetics to unravel the complexities of disease
and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its manufacturing expertise to
strive for solutions dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen
has grown to be the world’s largest independent biotechnology company, has reached millions of
patients around the world and is developing a pipeline of medicines with breakaway potential.
www.arlar.org
117
ARLAR
Bottu
Based in Casablanca, the economic capital of Morocco, Bottu is an integrated pharmaceutical
company. Its mission is to ensure access to essential medicinal drugs to prevent and cure the
most common diseases, improving thereby the health and well-being of all.
Strong with the know-how and expertise it has acquired over the years, Bottu is involved in all
the parts of the medicinal drug value chain. It develops, manufactures, packages, distributes
and promotes several products, either under its own name or other brands.
Cooper
Based in Casablanca since 1933, Cooper Pharma, a leading pharmaceutical company in Morocco
is working with health professionals to achieve a mission: offering to the largest number of
people access to quality drugs.
Today, Cooper Pharma is proposing more than 100 pharmaceutical specialties of its branded
generics portfolio in the major therapeutic areas. Alongside with its own brand, Cooper Pharma
manufacture, import, market and promote a hundred of drugs under license from more than 20
international companies.
Cooper Pharma represents a unique model in Morocco with its triple activity: producer,
distributor and exporter of pharmaceutical specialties. This model is based on an industrial
tool at the cutting edge of technology, certified by the leading health authorities: French Health
authority (ANSM); Saudi Health authority (Saudi FDA), GMP Morocco,…, and recognized to
produce drugs meeting the highest international quality standards.
Bronze Sponsor
HIKMA
The Group was founded in 1978 in Amman, Jordan by Mr. Samih Darwazah, its former Chairman
and Chief Executive Officer. At the time of its foundation, the Group was focused on establishing
its Branded business in the MENA region. In the early 1990s, the Group expanded outside the
MENA region by establishing injectable pharmaceutical operations in Portugal and acquiring
West-Ward Pharmaceuticals in the United States. Over the following ten years, the Group
significantly expanded its operations in the United States, the MENA region and Europe through
organic growth and investment in Greenfield projects. In 2005, the Group was listed on the
London Stock Exchange. From 2005 onwards, the Group has expanded its presence in existing
markets and entered new markets in the MENA region. It has also made significant acquisitions
in Europe and the United States to strengthen its Injectables business. In 2011 Hikma entered
the Moroccan market, with Promopharm being its local affiliate.
Gold Sponsor
Janssen
The Janssen team in immunology comprises a diverse global network of people and partnerships
with one overarching mission: to solve unmet medical needs in immune-mediated inflammatory
diseases and allow patients with these debilitating diseases to lead normal lives. We believe
that our history, our collaborations and our dedicated team of scientists put us at the forefront
of immunology research, allowing us to develop cutting edge treatments that address the needs
of millions of patients diagnosed with immune-mediated inflammatory diseases worldwide.
Committed Leaders in Immunology
At Janssen we work closely with leading experts around the world in academia, industry, and
patient and professional organisations. Collectively, we share a vision of providing new hope and
good health for people and their families who are living with immunological diseases.
Some of the most common forms of these diseases include rheumatoid arthritis, inflammatory
bowel disease and psoriasis, but there are also many other types of immune-mediated
118
www.arlar.org
119
ARLAR
inflammatory diseases. The impact of living with these conditions can be physically and
emotionally overwhelming as they are often debilitating and seriously diminish quality of life.
They also have an impact on the lives of patients’ families and the people who care for them.
Our History
We take our name from Dr Paul Janssen who began his research in Belgium more than half a
century ago. Dr Paul, as he was known, was a gifted and passionate scientist and entrepreneur,
but was first and foremost a doctor who wanted to help patients. His combination of scientific
excellence with a deep concern for humanity and a visionary management still inspires us today.
h.i
PHI - A national laboratory to multinational standards
The quality at the heart of our strategy
We are a healthcare company, and we recognize the importance of transparency and its role in
the development of relationships of trust with our stakeholders, and especially with patients. We
conduct our business in an ethical and responsible manner, and this commitment applies to all
of our activities, and we comply with all applicable laws and regulations:
• A factory with GMP international standards audited regularly by its partners.
• Raw materials comply with the requirements of the European Pharmacopoeia
• A team trained in the practices of international quality standards
• Highly qualified and validated equipment to international standards
• Bioequivalence studies.
120
Platinum Sponsor
Pfizer Inc
Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and
significantly improve their lives. We strive to set the standard for quality, safety and value in the
discovery, development and manufacture of health care products. Our global portfolio includes
medicines and vaccines as well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and emerging markets to advance
wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier innovative biopharmaceutical
companies, we collaborate with health care providers, governments and local communities to
support and expand access to reliable, affordable health care around the world. For more than
150 years, Pfizer has worked to make a difference for all who rely on us.
Bronze Sponsor
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to
improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated
medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the
central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based
cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of
pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised
healthcare – a strategy that aims to fit the right treatment to each patient in the best way
possible.
www.arlar.org
121
ARLAR
Networking Dinner
Share an unforgettable evening at ‘Chez Ali‘
Come and meet us for a dinner away from the bustle of the Congress, in a magical location in
the center of the Palmeraie to share the rhythms and values dear to the Marrakchi hospitality.
Beautiful and authentic, Chez Ali is the institution that represents the best the art of Moroccan
conviviality around a dinner full of local flavours.
We will share an unforgettable moment punctuated with traditional dances and performances !
Sanofi
About Sanofi in Morocco
Sanofi has been present in Morocco for over 50 years and is the market leader in the country.
It has a workforce of 700 people, including the Maphar production site, a pharmaceutical
development center, and a new logistics platform. The Maphar production site, located in
Zenata, Casablanca, is certified by the World Health Organization and produced 50 million units
in 2015, Sanofi’s activities in Morocco include registering, producing, distributing and marketing
pharmaceutical products (including innovative, traditional, and generic medicines, vaccines and
consumer-health products) as well as dietary products and medical devices.www.sanofi.ma,
www.maphar.ma
Une soirée de partage dans la plus grande convivialité au restaurant Chez Ali
Retrouvons nous pour une soirée loin de l’effervescence du Congrès, dans un lieu magique au
centre de la Palmeraie, aux rythmes des valeurs chères à l’hospitalité marrakchie.
Grandiose et authentique, le restaurant Chez Ali est une institution dans la représentation de
l’art et de la convivialité marocaine autour d’un dîner aux saveurs locales.
Nous partagerons un moment inoubliable ponctué de danses et spectacles traditionnels !
Friday 25 March / vendredi 25 mars
Price / prix: 65USD
including transportation - bus departure at 20:00 in front of Palais des Congrès. More information
at First Class Travel Desk in the registration area.
Sothema
SOTHEMA is a 100% Morroccan pharmaceutical company specializing in manufacturing and
marketing drugs since 1976. SOTHEMA represents 35 multinational companies among the
world leaders in Research & Development.
The Networking Dinner is kindly sponsored by
122
www.arlar.org
123
ARLAR
Accommodation and Travel / Hotellerie et Billeterie
Atlas Medina & SPA 5*
Avenue Mohamed VI
Tel : 00212 5 24 33 39 50
Le Méridien N’fis 5*
Avenue Mohamed VI
Tel : 00212 5 24 33 94 00
Savoy Le Grand Hôtel 5*
Avenue Menara
Tel : 00212 5 24 35 10 00
Atlas Asni 4*
Avenue Mohamed VI
Tel : 00212 5 24 33 99 00
Riad Mogador 4*L (classé 5*)
Avenue Mohamed VI
Tel : 00212 5 24 33 93 30
Kenzi Farah 4*L (classé 5*)
Avenue Kennedy
Tel : 00212 5 24 44 74 00
Les Idrissides 3* L (classé 4*)
Avenue Mohamed VI
Tel : 00212 5 24 33 90 00
Accommodation / Hotellerie
First Class Travel
Avenue Hassan 1er / Marrakech
Tel (lignes groupées) : 00212 5 24 43 03 31/29
www.firstclasstravel-marrakech.com
Transport Aérien / Flight Reservation
Z Tours
312, Avenue du Prince My Abdellah
Résidence Al Hamra A N° 41
Marrakech 40090
Tel : 00 212 5 24 312 002
Morocco
124
Our preferred Partner / Notre partenaire:
Royal Air Maroc
www.arlar.org
125
ARLAR
Download
our App now!
126

Final Programme - Société Marocaine de Rhumatologie

Transcription

Similar documents

chourouk hriech

Fibroses pulmonaires des connectivites

Maroc Week-end trendy à Marrakech Maroc Week-end

communiqué de presse

20, via toiano palaia, toscana +39 05876 32128

Aller à la ressource

About JLL Morocco

7 International Conference